<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">15887</article-id><article-id pub-id-type="doi">10.7554/eLife.15887</article-id><article-categories><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group><subj-group subj-group-type="display-channel"><subject>Short Report</subject></subj-group></article-categories><title-group><article-title>The endoplasmic reticulum, not the pH gradient, drives calcium refilling of lysosomes</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes" id="author-22454"><name><surname>Garrity</surname><given-names>Abigail G</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib">†</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-34390"><name><surname>Wang</surname><given-names>Wuyang</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="equal-contrib">†</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-35382"><name><surname>Collier</surname><given-names>Crystal MD</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-35383"><name><surname>Levey</surname><given-names>Sara A</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-34392"><name><surname>Gao</surname><given-names>Qiong</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-14163"><name><surname>Xu</surname><given-names>Haoxing</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-3561-4654</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution content-type="dept">Neuroscience Program</institution>, <institution>University of Michigan</institution>, <addr-line><named-content content-type="city">Ann Arbor</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><label>2</label><institution content-type="dept">Department of Molecular, Cellular, and Developmental Biology</institution>, <institution>University of Michigan</institution>, <addr-line><named-content content-type="city">Ann Arbor</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Clapham</surname><given-names>David E</given-names></name><role>Reviewing editor</role><aff id="aff3"><institution>Howard Hughes Medical Institute, Boston Children's Hospital</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><email>haoxingx@umich.edu</email></corresp><fn fn-type="con" id="equal-contrib"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date date-type="pub" publication-format="electronic"><day>23</day><month>05</month><year>2016</year></pub-date><pub-date pub-type="collection"><year>2016</year></pub-date><volume>5</volume><elocation-id>e15887</elocation-id><history><date date-type="received"><day>09</day><month>03</month><year>2016</year></date><date date-type="accepted"><day>20</day><month>05</month><year>2016</year></date></history><permissions><copyright-statement>© 2016, Garrity et al</copyright-statement><copyright-year>2016</copyright-year><copyright-holder>Garrity et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-15887-v2.pdf"/><abstract><object-id pub-id-type="doi">10.7554/eLife.15887.001</object-id><p>Impaired homeostasis of lysosomal Ca<sup>2+</sup> causes lysosome dysfunction and lysosomal storage diseases (LSDs), but the mechanisms by which lysosomes acquire and refill Ca<sup>2+</sup> are not known. We developed a physiological assay to monitor lysosomal Ca<sup>2+</sup> store refilling using specific activators of lysosomal Ca<sup>2+</sup> channels to repeatedly induce lysosomal Ca<sup>2+</sup> release. In contrast to the prevailing view that lysosomal acidification drives Ca<sup>2+</sup> into the lysosome, inhibiting the V-ATPase H<sup>+</sup> pump did not prevent Ca<sup>2+</sup> refilling. Instead, pharmacological depletion or chelation of Endoplasmic Reticulum (ER) Ca<sup>2+</sup> prevented lysosomal Ca<sup>2+</sup> stores from refilling. More specifically, antagonists of ER IP3 receptors (IP3Rs) rapidly and completely blocked Ca<sup>2+</sup> refilling of lysosomes, but not in cells lacking IP3Rs. Furthermore, reducing ER Ca<sup>2+</sup> or blocking IP3Rs caused a dramatic LSD-like lysosome storage phenotype. By closely apposing each other, the ER may serve as a direct and primary source of Ca<sup>2+</sup>for the lysosome.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.15887.001">http://dx.doi.org/10.7554/eLife.15887.001</ext-link></p></abstract><kwd-group kwd-group-type="author-keywords"><title>Author Keywords</title><kwd>lysosome</kwd><kwd>calcium</kwd><kwd>ER</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research Organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000052</institution-id><institution>NIH Office of the Director</institution></institution-wrap></funding-source><award-id>NS062792</award-id><principal-award-recipient><name><surname>Garrity</surname><given-names>Abigail G</given-names></name><name><surname>Wang</surname><given-names>Wuyang</given-names></name><name><surname>Collier</surname><given-names>Crystal MD</given-names></name><name><surname>Levey</surname><given-names>Sara A</given-names></name><name><surname>Gao</surname><given-names>Qiong</given-names></name><name><surname>Xu</surname><given-names>Haoxing</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000052</institution-id><institution>NIH Office of the Director</institution></institution-wrap></funding-source><award-id>AR060837</award-id><principal-award-recipient><name><surname>Garrity</surname><given-names>Abigail G</given-names></name><name><surname>Wang</surname><given-names>Wuyang</given-names></name><name><surname>Collier</surname><given-names>Crystal MD</given-names></name><name><surname>Levey</surname><given-names>Sara A</given-names></name><name><surname>Gao</surname><given-names>Qiong</given-names></name><name><surname>Xu</surname><given-names>Haoxing</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta><meta-name>elife-xml-version</meta-name><meta-value>2.5</meta-value></custom-meta><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>The endoplasmic reticulum serves as a direct and primary source of calcium ions for the lysosome.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>A vacuolar-type H<sup>+</sup>-ATPase (V-ATPase) on the membrane of the lysosome maintains the acidic lumen (pH<sub>Ly</sub> ~ 4.6), and improper acidification of lysosomes may lead to lysosomal storage diseases (LSDs) (<xref ref-type="bibr" rid="bib38">Mindell, 2012</xref>). Like the Endoplasmic Reticulum (ER) (<xref ref-type="bibr" rid="bib9">Clapham, 2007</xref>; <xref ref-type="bibr" rid="bib4">Berridge, 2012</xref>), lysosomes are also intracellular Ca<sup>2+</sup> stores with free [Ca<sup>2+</sup>]<sub>Ly</sub> ~0.4–0.6 mM (<xref ref-type="bibr" rid="bib8">Christensen et al., 2002</xref>; <xref ref-type="bibr" rid="bib31">Lloyd-Evans et al., 2008</xref>), which is 3–4 orders of magnitude higher than the cytosolic [Ca<sup>2+</sup>] (~100 nM). A reduction in [Ca<sup>2+</sup>]<sub>Ly</sub> is believed to be the primary pathogenic cause for some LSDs and common neurodegenerative diseases (<xref ref-type="bibr" rid="bib31">Lloyd-Evans et al., 2008</xref>; <xref ref-type="bibr" rid="bib10">Coen et al., 2012</xref>). Using the fast Ca<sup>2+</sup> chelator BAPTA, Ca<sup>2+</sup> release from the lysosome has been shown to be required for late endosome-lysosome fusion (<xref ref-type="bibr" rid="bib46">Pryor et al., 2000</xref>), lysosomal exocytosis, phagocytosis, membrane repair, and signal transduction (<xref ref-type="bibr" rid="bib48">Reddy et al., 2001</xref>; <xref ref-type="bibr" rid="bib30">Lewis, 2007</xref>; <xref ref-type="bibr" rid="bib27">Kinnear et al., 2004</xref>). Consistently, the principal Ca<sup>2+</sup> channel in the lysosome, Mucolipin TRP channel 1 (TRPML1 or ML1), as well as lysosomal Ca<sup>2+</sup> sensors such as the C2 domain–containing synaptotagmin VII, are also required for these functions (<xref ref-type="bibr" rid="bib54">Steen et al., 2007</xref>; <xref ref-type="bibr" rid="bib30">Lewis, 2007</xref>; <xref ref-type="bibr" rid="bib27">Kinnear et al., 2004</xref>). Whereas human mutations of <italic>TRPML1</italic> cause type IV Mucolipidosis, pathogenic inhibition of ML1 underlies several other LSDs (<xref ref-type="bibr" rid="bib53">Shen et al., 2012</xref>).</p><p>How the 5000-fold Ca<sup>2+</sup> concentration gradient across the lysosomal membrane is established and maintained is poorly understood. The most well understood Ca<sup>2+</sup> store in the cell is the ER. Upon store depletion, the luminal sensor protein STIM1 oligomerizes to activate the highly Ca<sup>2+</sup>-selective ORAI/CRAC channels on the plasma membrane, refilling the ER Ca<sup>2+</sup> store via the SERCA pump (<xref ref-type="bibr" rid="bib9">Clapham, 2007</xref>; <xref ref-type="bibr" rid="bib30">Lewis, 2007</xref>; <xref ref-type="bibr" rid="bib4">Berridge, 2012</xref>). However, depletion of lysosomal Ca<sup>2+</sup> stores does not induce extracellular Ca<sup>2+</sup> entry (<xref ref-type="bibr" rid="bib19">Haller et al., 1996b</xref>). The endocytic pathway may theoretically deliver extracellular Ca<sup>2+</sup> to lysosomes. However, most Ca<sup>2+</sup> taken up through endocytosis is lost quickly during the initial course of endosomal acidification prior to reaching lysosomes during endosome maturation (<xref ref-type="bibr" rid="bib17">Gerasimenko et al., 1998</xref>). In various cell types, when the lysosomal pH gradient is dissipated, either by inhibiting the V-ATPase or by alkalizing reagents such as NH<sub>4</sub>Cl, free <italic>luminal</italic> [Ca<sup>2+</sup>]<sub>Ly</sub> was found to drop drastically (<xref ref-type="bibr" rid="bib6">Calcraft et al., 2009</xref>; <xref ref-type="bibr" rid="bib8">Christensen et al., 2002</xref>; <xref ref-type="bibr" rid="bib12">Dickson et al., 2012</xref>; <xref ref-type="bibr" rid="bib31">Lloyd-Evans et al., 2008</xref>; <xref ref-type="bibr" rid="bib53">Shen et al., 2012</xref>), with no or very small concomitant increase in <italic>cytosolic</italic> Ca<sup>2+</sup> (<xref ref-type="bibr" rid="bib8">Christensen et al., 2002</xref>; <xref ref-type="bibr" rid="bib12">Dickson et al., 2012</xref>). These findings have been interpreted to mean that the proton gradient in the lysosome is responsible for actively driving Ca<sup>2+</sup> into the lysosome via an unidentified H<sup>+</sup>-dependent Ca<sup>2+</sup> transporter (<xref ref-type="bibr" rid="bib41">Morgan et al., 2011</xref>). Because these findings are consistent with studies in yeast showing that the Ca<sup>2+</sup>/H<sup>+</sup> exchangers establish the vacuolar Ca<sup>2+</sup> gradient (<xref ref-type="bibr" rid="bib41">Morgan et al., 2011</xref>), this 'pH hypothesis' has been widely accepted (<xref ref-type="bibr" rid="bib6">Calcraft et al., 2009</xref>; <xref ref-type="bibr" rid="bib8">Christensen et al., 2002</xref>; <xref ref-type="bibr" rid="bib31">Lloyd-Evans et al., 2008</xref>; <xref ref-type="bibr" rid="bib41">Morgan et al., 2011</xref>; <xref ref-type="bibr" rid="bib53">Shen et al., 2012</xref>). However, large, prolonged manipulations of luminal pH may interfere directly with Ca<sup>2+</sup> reporters, and secondarily affect many other lysosomal processes, especially lysosome luminal Ca<sup>2+</sup> buffering (<xref ref-type="bibr" rid="bib12">Dickson et al., 2012</xref>), lysosome membrane potential, and fusion/fission of endosomes and lysosomes (<xref ref-type="bibr" rid="bib38">Mindell, 2012</xref>). Therefore, these hypotheses about lysosomal Ca<sup>2+</sup> refilling and store maintenance remain to be tested under more physiological conditions. Directly measuring lysosomal Ca<sup>2+</sup> release has been made possible recently by using lysosome-targeted genetically-encoded Ca<sup>2+</sup> indicators (<xref ref-type="bibr" rid="bib53">Shen et al., 2012</xref>) (GCaMP3-ML1; see <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>), which co-localized well, in healthy cells, with lysosomal associated membrane protein-1 (Lamp1), but not with markers for the ER, mitochondria, or early endosomes (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B</xref>).</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>A physiological assay to monitor lysosomal Ca<sup>2+</sup> refilling</title><p>Monitoring lysosomal Ca<sup>2+</sup> store refilling requires direct activation of lysosomal Ca<sup>2+</sup> channels with specific agonists to repeatedly induce Ca<sup>2+</sup> release. NAADP, the only known endogenous Ca<sup>2+</sup>-mobilizing messenger that has been suggested to be lysosome-specific, was not useful due to its membrane impermeability and strong desensitization (<xref ref-type="bibr" rid="bib41">Morgan et al., 2011</xref>). Using the specific, membrane–permeable synthetic agonists that we recently identified for lysosomal TRPML1 channels (ML-SA1) (<xref ref-type="bibr" rid="bib53">Shen et al., 2012</xref>), we developed a lysosomal Ca<sup>2+</sup> refilling assay as shown in <xref ref-type="fig" rid="fig1">Figure 1A</xref>. In HEK293 cell lines stably-expressing GCaMP3-ML1 (HEK-GCaMP3-ML1 cells), bath application of ML-SA1 (30s) in a 'zero' (low; free [Ca<sup>2+</sup>] &lt;10 nM) Ca<sup>2+</sup> external solution produced robust lysosomal Ca<sup>2+</sup> release measured by GCaMP3 fluorescence (△F/F<sub>0</sub> &gt;0.5; <xref ref-type="fig" rid="fig1">Figure 1A,B</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>, <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2A</xref>). The membrane-permeable form of the fast Ca<sup>2+</sup> chelator BAPTA (BAPTA-AM) completely blocked the ML-SA1 response (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1D</xref>), supporting its Ca<sup>2+</sup> specificity. Importantly, GCaMP3-ML1-tagged lysosomes co-localized well with LysoTracker, indicating that the pH of these lysosomes was not different from lysosomes without GCaMP3-ML1 (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1E</xref>).<fig-group><fig id="fig1" position="float"><object-id pub-id-type="doi">10.7554/eLife.15887.002</object-id><label>Figure 1.</label><caption><title>The proton gradient of the lysosome is not required for lysosomal Ca<sup>2+</sup> store refilling.</title><p>(<bold>A</bold>) In HEK293 cells stably expressing GCaMP3-ML1 (HEK-GCaMP3-ML1 cells), bath application of the ML1 channel agonist ML-SA1 (20 µM) in a low or 'zero' Ca<sup>2+</sup> (free [Ca<sup>2+</sup>]&lt;10 nM) external solution induced an increase in GCaMP3 fluorescence (F<sub>470</sub>). After washout for 5 min, repeated applications of ML-SA1 induced responses that were similar to or larger than the first one. Note that because baseline may drift during the entire course of the experiment (up to 20 min), we typically set F<sub>0</sub> based on the value that is closest to the baseline. (<bold>B</bold>) The average Ca<sup>2+</sup> responses of three ML-SA1 applications at intervals of 5 min (n=26 coverslips; <xref ref-type="supplementary-material" rid="SD1-data">Figure 1<italic>—</italic>source data 1</xref>). (<bold>C</bold>) Pre-treatment with lysosome-disrupting agent GPN for 30 min abolished the response to ML-SA1 in HEK-GCaMP3-ML1 cells. Washout of GPN resulted in a gradual re-appearance of ML-SA1 responses. See quantitation in <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2K</xref>. (<bold>D</bold>) Repeated applications of GPN resulted in Ca<sup>2+</sup> release that was measured with the Ca<sup>2+</sup>-sensitive dye Fura-2 (F<sub>340</sub>/F<sub>380</sub>) in non-transfected HEK293T cells. (<bold>E</bold>) Application of Bafilomycin-A (Baf-A, 5 µM) and Concanamycin-A (Con-A, 1 µM) quickly (&lt;5 min) abolished LysoTracker staining, an indicator of acidic compartments. (<bold>F</bold>) Acute application of Baf-A (5 µM) for 5 min did not block Ca<sup>2+</sup> refilling of lysosomes in HEK-GCaMP3-ML1 cells. (<bold>G</bold>) Prolonged pre-treatment (3 hr) with Baf-A did not block Ca<sup>2+</sup> refilling of lysosomes. (<bold>H</bold>) Quantification of 1<sup>st</sup> (p value = 0.11), 2<sup>nd</sup> (p=0.01), and 3<sup>rd</sup> (p=0.004) ML-SA1 responses upon Baf-A treatment (n=8) compared to control traces (n=6; <xref ref-type="supplementary-material" rid="SD1-data">Figure 1<italic>—</italic>source data 1</xref>). (<bold>I</bold>) Prolonged treatment (1 hr) with Con-A did not prevent lysosomes from refilling their Ca<sup>2+</sup> stores. (<bold>J</bold>) Quantification of 1st (p=0.90), 2nd (p=0.33), and 3rd (p=0.66) ML-SA1 responses with Con-A pre-treatment (n=3; <xref ref-type="supplementary-material" rid="SD1-data">Figure 1<italic>—</italic>source data 1</xref>). (<bold>K</bold>) Con-A did not reveal differences in Ca<sup>2+</sup> refilling responses to repeated applications of GPN in untransfected HEK293T cells. Panels <bold>A</bold>, <bold>C</bold>, <bold>D</bold>, <bold>F</bold>, <bold>G</bold>, <bold>I</bold>, and <bold>K</bold> are the average of 30–40 cells from one representative coverslip/experiment. The data in panels <bold>B</bold>, <bold>H</bold>, and <bold>J</bold> represent mean ± SEM from at least three independent experiments.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.15887.002">http://dx.doi.org/10.7554/eLife.15887.002</ext-link></p><p><supplementary-material id="SD1-data"><object-id pub-id-type="doi">10.7554/eLife.15887.003</object-id><label>Figure 1—source data 1.</label><caption><title>Source data of <xref ref-type="fig" rid="fig1">Figure 1B, H, J</xref>: The average Ca<sup>2+</sup> responses to ML-SA1 applications under control (<bold>B</bold>), Baf-A1 treatment (<bold>H</bold>), and Con-A treatment (<bold>J</bold>).</title><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.15887.003">http://dx.doi.org/10.7554/eLife.15887.003</ext-link></p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-15887-fig1-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="jpeg" mimetype="image" xlink:href="elife-15887-fig1-v2.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.15887.004</object-id><label>Figure 1—figure supplement 1.</label><caption><title>A lysosome-targeted genetically-encoded Ca<sup>2+</sup> indicator to measure lysosomal Ca<sup>2+</sup> release, store depletion, and refilling.</title><p>(<bold>A</bold>) Detection of lysosomal Ca<sup>2+</sup> release by a genetically-encoded Ca<sup>2+</sup> indicator (GCaMP3) fused directly to the N-terminus of ML1 (GCaMP3-ML1). (<bold>B</bold>) Co-localization analyses between GCaMP3-ML1 and various organellar markers, including Lamp1-mCherry, CFP-ER, Mito-tracker, and EEA1-mCherry. Scale bars = 5 μm. (<bold>C</bold>) In an HEK-GCaMP3-ML1 cell, both ML-SA1 and subsequent ionomycin induced GCaMP3 fluorescence increases in lysosomes shown by both fluorescence imaging and Ca<sup>2+</sup> imaging. (<bold>D</bold>) BAPTA-AM pre-treatment abolished ML-SA1-induced responses in HEK-GCaMP3-ML1 cells. Panel C shows the average response of 30–40 cells from one representative experiment. (<bold>E</bold>) Cos7 cells transfected with GCaMP3-ML1 show strong co-localization with LysoTracker, which is highly selective for acidic organelles.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.15887.004">http://dx.doi.org/10.7554/eLife.15887.004</ext-link></p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-15887-fig1-figsupp1-v2.tif"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.15887.005</object-id><label>Figure 1—figure supplement 2.</label><caption><title>An assay to monitor lysosomal Ca<sup>2+</sup> store depletion and refilling.</title><p>(<bold>A</bold>) Raw traces of ML-SA1-induced GCaMP3 Ca<sup>2+</sup> responses of individual HEK-GCaMP3-ML1 cells on one coverslip. (<bold>B</bold>) Immediate re-application of ML-SA1 showed a nearly-abolished lysosomal Ca<sup>2+</sup> release. (<bold>C</bold>) In HEK293T cells transfected with surface-expressed TRPML1-4A channels, repeated applications of ML-SA1 induced comparable responses. (<bold>D</bold>) After 1 min refilling time, application of ML-SA1 in HEK-GCaMP3-ML1 cells induced responses that were smaller than the first one. (<bold>E</bold>) The amount of Ca<sup>2+</sup> released after 8 min of washout and refilling was similar to the amount released after 5 min. (<bold>F</bold>) Time-dependence of lysosomal Ca<sup>2+</sup> store refilling. (<bold>G</bold>) In the presence of La<sup>3+</sup> (100 μM), a membrane-impermeable TRPML blocker, GPN pretreatment abolished ML-SA1-induced responses in HEK-GCaMP3-ML1 cells. (<bold>H</bold>) Lysosomal Ca<sup>2+</sup> refilling in the presence of La<sup>3+</sup>. (<bold>I</bold>) ML-SI3 (5 μM) reversibly inhibited ML-SA1-induced Ca<sup>2+</sup> responses in HEK-GCaMP3-ML1 cells. (<bold>J</bold>) Normalized ML-SA1 responses with and without co-application of MI-SI3. (<bold>K</bold>) Quantification of ML-SA1 responses shown in <xref ref-type="fig" rid="fig1">Figure 1C</xref>. (<bold>L</bold>) Lysosomal Ca<sup>2+</sup> refilling in human fibroblasts transfected with GCaMP3-ML1. (<bold>M</bold>) Lysosomal Ca<sup>2+</sup> refilling in Cos-7 cells transfected with GCaMP3-ML1. Panel <bold>B</bold>, <bold>D</bold>, <bold>E</bold>, <bold>G</bold>, <bold>H</bold>, <bold>I</bold>, <bold>L</bold> and M show the average response of 30–40 cells from one representative experiment out of at least independent repeats.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.15887.005">http://dx.doi.org/10.7554/eLife.15887.005</ext-link></p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-15887-fig1-figsupp2-v2.tif"/></fig><fig id="fig1s3" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.15887.006</object-id><label>Figure 1—figure supplement 3.</label><caption><title>GPN and ML-SA1 have different effects on lysosome pH and GCaMP3 fluorescence.</title><p>(<bold>A</bold>) LysoTracker staining was not affected by ML-SA1 (20 μM), but was abolished by GPN (400 μM). Scale bar = 15 µm. (<bold>B</bold>) Pretreatment of a membrane-permeable form of Ca<sup>2+</sup> chelator BAPTA (BAPTA-AM) for 2h abolished Fura-2 response to ATP in HEK293T cells. GPN still induced small increases in the Fura-2 signal in the same cells (also see panel <bold>C</bold>). (<bold>C</bold>) ATP and GPN Fura-2 responses in HEK293T cells. (<bold>D</bold>) GPN (400 μM) induced increases of GCaMP3 fluorescence in HEK-GCaMP3-ML1 cells that were pre-treated and kept in continuous presence of BAPTA-AM, and the increases were abolished by Baf-A1 co-treatment. Note that ionomycin was still able to induce GCaMP3 increases. Panels D show the average response of 30–40 cells from one representative experiment. (<bold>E</bold>) Representative traces showing GCaMP3 sensitivities to patch-electrode-based 'puffing' of low-pH and high-Ca<sup>2+</sup> solutions to GCaMP3-ML1-expressing vacuoles isolated from HEK-GCaMP3-ML1 cells.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.15887.006">http://dx.doi.org/10.7554/eLife.15887.006</ext-link></p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-15887-fig1-figsupp3-v2.tif"/></fig><fig id="fig1s4" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.15887.007</object-id><label>Figure 1—figure supplement 4.</label><caption><title>Inhibition of PI(3,5)P<sub>2</sub> production does not prevent lysosomal Ca<sup>2+</sup> refilling.</title><p>Representative Ca<sup>2+</sup> imaging traces showing lysosomal Ca<sup>2+</sup> refilling in GCaMP3-ML1 cells pretreated with Apilimod (<bold>A</bold>) or YM201636 (<bold>B</bold>). Panels <bold>A</bold> and <bold>B</bold> show the average response of 30–40 cells from one representative experiment.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.15887.007">http://dx.doi.org/10.7554/eLife.15887.007</ext-link></p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-15887-fig1-figsupp4-v2.tif"/></fig></fig-group></p><p>After release of the initial, 'naïve' Ca<sup>2+</sup> store upon first application of ML-SA1, lysosomal Ca<sup>2+</sup> stores are largely depleted, as immediate re-application of ML-SA1 evoked much smaller or no response (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2B</xref>). The reduction in the second response was unlikely caused by channel desensitization, as surface-expressed TRPML1 mutant (TRPML1-4A [<xref ref-type="bibr" rid="bib53">Shen et al., 2012</xref>]) showed repeated Ca<sup>2+</sup> entry in Ca<sup>2+</sup>-containing (2 mM) external solution (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2C</xref>). Notably, increasing the time interval between consecutive applications quickly and effectively restored the lysosomal ML-SA1 responses; it required 5 min for full restoration/refilling (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2D–F</xref>). With 5 min of refilling time (chosen for the rest of our experiments), in healthy HEK-GCaMP3-ML1 cells, the second and third ML-SA1 responses are often slightly higher than the first, naïve response (<xref ref-type="fig" rid="fig1">Figure 1A,B</xref>).</p><p>To ensure the ML-SA1-induced Ca<sup>2+</sup> responses are exclusively intracellular and lysosomal, all ML-SA1 responses were measured either in the 'zero' Ca<sup>2+</sup> external solution (<xref ref-type="fig" rid="fig1">Figure 1A</xref>) or in the presence of La<sup>3+</sup> (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2G,H</xref>), a membrane-impermeable TRPML channel blocker (<xref ref-type="bibr" rid="bib13">Dong et al., 2008</xref>) that is expected to completely inhibit surface-expressed TRPML1 channels. Ca<sup>2+</sup> release was completely blocked by the TRPML-specific, synthetic antagonists ML-SI1 or ML-SI3 (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2I,J</xref>). In addition, pretreatment with the lysosome-disrupting reagent Glycyl-L-phenylalanine 2-naphthylamide (GPN) (<xref ref-type="bibr" rid="bib3">Berg et al., 1994</xref>) also completely abolished the refilling either in 'zero' Ca<sup>2+</sup> or in the presence of La<sup>3+</sup> (<xref ref-type="fig" rid="fig1">Figure 1C</xref>; <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2G</xref>), further supporting the lysosome-specificity of the response. The effect of GPN, presumably on so-called 'lysosomal membrane permeabilization', is known to be rapid and reversible (i.e. membrane 'resealing') (<xref ref-type="bibr" rid="bib26">Kilpatrick et al., 2013</xref>). Consistently, washout of GPN led to gradual recovery of ML-SA1 responses (<xref ref-type="fig" rid="fig1">Figure 1C</xref>; <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2K</xref>). Similar Ca<sup>2+</sup> refilling of lysosomes was also observed in GCaMP3-ML1-transfected human fibroblasts (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2L</xref>), Cos-7 cells (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2M</xref>), primary mouse macrophages, mouse myoblasts, and DT40 chicken B cells (<xref ref-type="fig" rid="fig3">Figure 3D–E</xref>’). These findings support the idea that these responses are mediated by intracellular Ca<sup>2+</sup> release from refilled lysosomal stores (also see <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1C</xref> for signals from individual lysosomes). Taken together, these results ensure that lysosomal Ca<sup>2+</sup> stores can be emptied and refilled repeatedly and consistently in a time-dependent manner.</p></sec><sec id="s2-2"><title>Studying lysosomal Ca<sup>2+</sup> refilling using a lysosome-specific 'membrane-permeabilizer'</title><p>GPN is a membrane-permeable di-peptide that is broken down by the lysosome-specific enzyme Cathepsin C. GPN causes permeabilization of lysosome membranes resulting from the accumulation of its breakdown products within lysosomes (<xref ref-type="bibr" rid="bib3">Berg et al., 1994</xref>). Because it is a lysosome-specific membrane disrupting agent, it is often used to mobilize lysosome-specific Ca<sup>2+</sup> stores (<xref ref-type="bibr" rid="bib22">Jadot et al., 1984</xref>; <xref ref-type="bibr" rid="bib41">Morgan et al., 2011</xref>; <xref ref-type="bibr" rid="bib3">Berg et al., 1994</xref>; <xref ref-type="bibr" rid="bib18">Haller et al., 1996a</xref>; <xref ref-type="bibr" rid="bib19">Haller et al., 1996b</xref>). Using Fura-2 Ca<sup>2+</sup> imaging in non-transfected HEK293T cells, repeated applications of GPN resulted in a response of similar magnitude to the first, suggestive of Ca<sup>2+</sup> refilling (<xref ref-type="fig" rid="fig1">Figure 1D</xref>). Importantly, in HEK-GCaMP3-ML1 cells, pre-treatment with GPN or BAPTA-AM abolished the initial response to ML-SA1, confirming the GCaMP3-ML1 probe’s lysosome and Ca<sup>2+</sup> specificity (<xref ref-type="fig" rid="fig1">Figure 1C</xref>).</p><p>The GPN-mediated 'membrane permeabilizaton' causes the leakage of small solutes including Ca<sup>2+</sup> and H<sup>+</sup> into the cytosol (<xref ref-type="bibr" rid="bib2">Appelqvist et al., 2012</xref>), resulting in changes in the pH (see <xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3A</xref>) and [Ca<sup>2+</sup>] in both the lysosome lumen and the peri-lysosomal (juxta-lysosomal) cytosol (<xref ref-type="bibr" rid="bib3">Berg et al., 1994</xref>; <xref ref-type="bibr" rid="bib26">Kilpatrick et al., 2013</xref>; <xref ref-type="bibr" rid="bib2">Appelqvist et al., 2012</xref>). We therefore tested the Ca<sup>2+</sup>-specificity of GPN-induced increases on the Fura-2 and GCaMP3 signals. In cells pretreated with BAPTA-AM, whereas ER-mediated Ca<sup>2+</sup> responses were abolished, GPN-induced Fura-2 increases were much reduced but not abolished (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3B,C</xref>). Consistently, in HEK-GCaMP3-ML1 cells pre-treated with BAPTA-AM, GPN still induced a significant increase in GCaMP3 fluorescence. However, in these BAPTA-AM-treated cells, GPN-induced increases in GCaMP3 responses were completely abolished by a pre-treatment of Bafilomycin-A (Baf-A), a specific inhibitor of the V-ATPase (<xref ref-type="bibr" rid="bib41">Morgan et al., 2011</xref>) (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3D</xref>). Given that both Ca<sup>2+</sup> dyes and GFP-based Ca<sup>2+</sup> indicators are known to be sensitive to other ionic factors, particularly pH (<xref ref-type="bibr" rid="bib50">Rudolf et al., 2003</xref>), GPN-induced changes in lysosomal and peri-lysosomal pH could directly or indirectly account for the BAPTA-insensitive GCaMP3 and residual Fura-2 signals. Consistent with this prediction, in the vacuoles isolated from HEK-GCaMP3-ML1 cells, GCaMP3 fluorescence was sensitive not only to high Ca<sup>2+</sup>, but also to low pH (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3E</xref>). Because ratiometric dyes are less susceptible to pH changes (<xref ref-type="bibr" rid="bib39">Morgan et al., 2015</xref>), in the Fura-2 assay, GPN may induce a large Ca<sup>2+</sup> signal, but also a pH-mediated contaminating non-Ca<sup>2+</sup> signal (compare <xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3B with C</xref>).</p></sec><sec id="s2-3"><title>The pH gradient and V-ATPase are not required for lysosome Ca<sup>2+</sup> refilling</title><p>Next, we investigated the mechanisms underlying Ca<sup>2+</sup> refilling of lysosomes. Inhibition of endocytosis using dynasore and organelle mobility using cytoskeleton inhibitors such as nocodazole and trichostatin A did not block refilling (data not shown). Furthermore, disruption of Golgi function using Brefeldin-A also had no effect on refilling (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>). Hence, in agreement with previous findings, the secretory and endocytic pathways are not directly involved in Ca<sup>2+</sup> refilling. PI(3,5)P<sub>2</sub> is a lysosome-specific phosphoinositide that regulates multiple lysosomal channels and transporters including ML1 (<xref ref-type="bibr" rid="bib60">Xu and Ren, 2015</xref>). Pharmacologically decreasing PI(3,5)P<sub>2</sub> levels using two small molecule PIKfyve inhibitors: YM201636 (<xref ref-type="bibr" rid="bib23">Jefferies et al., 2008</xref>) and Apilimod (<xref ref-type="bibr" rid="bib5">Xu et al., 2013</xref>) did not prevent lysosomal Ca<sup>2+</sup> refilling (<xref ref-type="fig" rid="fig1s4">Figure 1—figure supplement 4A,B</xref>).</p><p>Previous findings have suggested that the pH gradient in the lysosome may be important to Ca<sup>2+</sup> refilling (<xref ref-type="bibr" rid="bib60">Xu and Ren, 2015</xref>; <xref ref-type="bibr" rid="bib41">Morgan et al., 2011</xref>), however few studies have carefully investigated this possibility. Baf-A and Concanamycin-A (Con-A), inhibitors of the V-ATPase, increase the pH of the lysosome (<xref ref-type="bibr" rid="bib41">Morgan et al., 2011</xref>), demonstrated by abolishing LysoTracker staining within minutes after application (<xref ref-type="fig" rid="fig1">Figure 1E</xref>). Surprisingly, acute application of Baf-A did not affect the response to ML-SA1, and had little effect on refilling (<xref ref-type="fig" rid="fig1">Figure 1F</xref>), nor did pretreatment of Baf-A for 1, 3 (<xref ref-type="fig" rid="fig1">Figure 1G,H</xref>), or 16 hr. Similarly, pretreatment with Con-A also had no effect on Ca<sup>2+</sup> refilling of lysosomes (<xref ref-type="fig" rid="fig1">Figure 1I, J, K</xref>). These findings suggest that contradictory to previous conclusions, the pH gradient and V-ATPase may not be required for Ca<sup>2+</sup> refilling, and that an alternative mechanism is responsible for supplying Ca<sup>2+</sup> to lysosomes.</p></sec><sec id="s2-4"><title>The Endoplasmic Reticulum (ER) Ca<sup>2+</sup> store is required for lysosomal Ca<sup>2+</sup> refilling</title><p>Lysosomal Ca<sup>2+</sup> refilling was drastically reduced upon removal of extracellular Ca<sup>2+</sup> during refilling time in HEK-GCaMP3-ML1 cells (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). However, blocking Ca<sup>2+</sup> entry using the generic cation channel blocker La<sup>3+</sup> did not prevent refilling (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B</xref>). Because ER stores are passively, although slowly, depleted in 0 Ca<sup>2+</sup> (<xref ref-type="bibr" rid="bib59">Wu et al., 2006</xref>) (also see <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1C</xref>), given the demonstrated role of extracellular Ca<sup>2+</sup> in ER store refilling (<xref ref-type="bibr" rid="bib30">Lewis, 2007</xref>; <xref ref-type="bibr" rid="bib4">Berridge, 2012</xref>), we investigated the role of the ER in lysosomal refilling. Thapsigargin (TG), a specific inhibitor of the ER SERCA pump (<xref ref-type="bibr" rid="bib55">Thastrup et al., 1990</xref>), rapidly and completely abolished Ca<sup>2+</sup> refilling to lysosomes (<xref ref-type="fig" rid="fig2">Figure 2B,G</xref>), but did not affect the first, naïve ML-SA1 response (<xref ref-type="fig" rid="fig2">Figure 2C</xref>; second response marked with arrow) or lysosomal pH (<xref ref-type="fig" rid="fig2">Figure 2D</xref>). In the GPN &amp; Fura-2 assay that provides a reasonable (but not perfect; see above) measurement of lysosomal Ca<sup>2+</sup> release independent of ML1, TG application also largely reduced the second GPN response (<xref ref-type="fig" rid="fig1">Figure 1D</xref>, <xref ref-type="fig" rid="fig2">2E</xref>), which could be further reduced or abolished by Baf-A pretreatment. These results suggest that TG had no direct effect on the naïve Ca<sup>2+</sup> store in lysosomes, but specifically and potently affected lysosomal Ca<sup>2+</sup> refilling. A rapid and complete block of Ca<sup>2+</sup> refilling was also observed for another SERCA pump inhibitor CPA (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1D–G</xref>). TG may induce an unfolded protein response (UPR; <xref ref-type="bibr" rid="bib33">Matsumoto et al., 2013</xref>). However, the UPR inducer Tunicamycin (<xref ref-type="bibr" rid="bib43">Oslowski and Urano, 2011</xref>) did not affect refilling (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1H,I</xref>).<fig-group><fig id="fig2" position="float"><object-id pub-id-type="doi">10.7554/eLife.15887.008</object-id><label>Figure 2.</label><caption><title>Lysosomal Ca<sup>2+</sup> refilling is dependent on the endoplasmic reticulum (ER) Ca<sup>2+</sup>.</title><p>(<bold>A</bold>) Ca<sup>2+</sup> refilling of lysosomes requires external Ca<sup>2+</sup>. (<bold>B</bold>) Dissipating the ER Ca<sup>2+</sup> gradient using SERCA pump inhibitor Thapsigargin (TG) blocked lysosomal Ca<sup>2+</sup> refilling in HEK-GCaMP3-ML1 cells. Three representative cells from among 30–40 cells on one coverslip are shown. Note that Ca<sup>2+</sup> release from the ER through passive leak revealed after blocking SERCA pumps was readily seen in HEK-GCaMP3-ML1 cells, presumably due to the close proximity between lysosomes and the ER (<xref ref-type="bibr" rid="bib26">Kilpatrick et al., 2013</xref>). (<bold>C</bold>) The effect of acute application of TG (2 μM) on the naïve ML-SA1 response and lysosomal Ca<sup>2+</sup> refilling in HEK-GCaMP3-ML1 cells. Application of TG did not affect the naïve, initial response to ML-SA1, but did abolish the refilled response (see arrow). Control naïve response 1.39 ± 0.09 (n=3); Naïve response after TG 1.08 ± 0.07 (n=3); p=0.2024). (<bold>D</bold>) LysoTracker staining was not reduced by TG (2 μM). (<bold>E</bold>) Representative Ca<sup>2+</sup> imaging trace and statistical data (right panel; <xref ref-type="supplementary-material" rid="SD2-data">Figure 2<italic>—</italic>source data 1</xref>) show that TG application reduced the second responses to GPN compared to the control shown in <xref ref-type="fig" rid="fig1">Figure 1D</xref>. (<bold>F</bold>) Chelating ER Ca<sup>2+</sup> using 2-min TPEN treatment blocked Ca<sup>2+</sup> refilling of lysosomes. (<bold>G</bold>) TG (p=0.008; n=5) and TPEN (p=0.001; n=5) abolished Ca<sup>2+</sup> refilling of lysosomes (<xref ref-type="supplementary-material" rid="SD2-data">Figure 2<italic>—</italic>source data 1</xref>). (<bold>H</bold>) In HEK-GCaMP3-ML1 cells that were transiently transfected with the IP3R-ligand binding domain with ER targeting sequence (IP3R-LBD-ER), which significantly reduces basal [Ca<sup>2+</sup>]<sub>ER</sub> (see <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2E</xref>), ML-SA1 responses were reduced, compared to untransfected cells on the same coverslip. (<bold>I</bold>) The 1st (p=0.0014), 2nd (p=0.0004), and 3rd responses (p&lt;0.0001) of GCaMP3-ML1 cells transfected with the IP3R-LBD-ER were significantly reduced compared to untransfected cells on the same coverslip (n=5; <xref ref-type="supplementary-material" rid="SD2-data">Figure 2<italic>—</italic>source data 1</xref>). (<bold>J</bold>) Lysosomes (labeled with Lamp1-mCherry) interact closely with the ER (labeled with CFP-ER). (<bold>K</bold>) Time lapse zoomed-in images of a selected region from <bold>J</bold> show the dynamics of ER-lysosome association (see an example in the boxed area). Panels <bold>A</bold>, <bold>F</bold>, <bold>H</bold> are the average responses of 30–40 cells from one representative experiment. The data in panel G represent mean ± SEM from five independent experiments.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.15887.008">http://dx.doi.org/10.7554/eLife.15887.008</ext-link></p><p><supplementary-material id="SD2-data"><object-id pub-id-type="doi">10.7554/eLife.15887.009</object-id><label>Figure 2—source data 1.</label><caption><title>Comparisons of GPN (<bold>E</bold>) and ML-SA1 responses (<bold>G</bold>, <bold>I</bold>) under different pharmacological and genetic manipulations (<xref ref-type="fig" rid="fig2">Figure 2E,G,I</xref>).</title><p>Comparisons of responses to ML-SA1 (<bold>E</bold>) and GPN (<bold>G</bold>) (<xref ref-type="fig" rid="fig2s1">Figure 2<italic>—</italic>figure supplement 1E,G</xref>).</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.15887.009">http://dx.doi.org/10.7554/eLife.15887.009</ext-link></p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-15887-fig2-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="jpeg" mimetype="image" xlink:href="elife-15887-fig2-v2.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.15887.010</object-id><label>Figure 2—figure supplement 1.</label><caption><title>The ER Ca<sup>2+</sup> store regulates lysosome Ca<sup>2+</sup> stores.</title><p>(<bold>A</bold>) The effect of Brefeldin-A (100 nM) pretreatment on lysosomal Ca<sup>2+</sup> refilling in HEK-GCaMP3-ML1 cells. (<bold>B</bold>) The effect of La<sup>3+</sup> (100 μM) pre-treatment on lysosomal Ca<sup>2+</sup> refilling in HEK-GCaMP3-ML1 cells. (<bold>C</bold>) The response to the endogenous P2Y receptor agonist ATP in HEK293T cells loaded with Fura-2 was abolished after perfusing cells with 0 external Ca<sup>2+</sup> for 5 min. (<bold>D</bold>, <bold>E</bold>) SERCA pump inhibitor cyclopiazonic acid (CPA) (100 μM) blocked Ca<sup>2+</sup> refilling of lysosomes (<xref ref-type="supplementary-material" rid="SD2-data">Figure 2<italic>—</italic>source data 1</xref>). (<bold>F</bold>, <bold>G</bold>) CPA markedly reduced the response to GPN in the Fura-2-loading cells. Note that the remaining response could be due to GPN-induced lysosomal H<sup>+</sup> release, which resulted in a change of pre-lysosomal pH that may in turn caused a Fura-2 signal (<xref ref-type="supplementary-material" rid="SD2-data">Figure 2<italic>—</italic>source data 1</xref>). (<bold>H</bold>) Tunicamycin (0.1 μg/ml) application did not affect the second responses to ML-SA1 in GCaMP3-ML1 cells. (<bold>I</bold>) Tunicamycin (0.5 μg/ml) did not induce lysosomal Ca<sup>2+</sup> releases. Panels <bold>A</bold>–<bold>I</bold> and <bold>K</bold> show the average response of 30–40 cells from one representative experiment.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.15887.010">http://dx.doi.org/10.7554/eLife.15887.010</ext-link></p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-15887-fig2-figsupp1-v2.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.15887.011</object-id><label>Figure 2—figure supplement 2.</label><caption><title>The ER Ca<sup>2+</sup> store regulates lysosome Ca<sup>2+</sup> stores.</title><p>(<bold>A</bold>) In un-transfected HEK293T cells, ATP induced Ca<sup>2+</sup> release through IP3-receptors on the ER, and GPN induced lysosomal Ca<sup>2+</sup> release. (<bold>B</bold>) A 2-min application of TPEN, a membrane-permeable chelator of luminal ER Ca<sup>2+</sup>, attenuated Ca<sup>2+</sup> release from IP3-receptors stimulated by ATP in HEK293T cells. (<bold>C</bold>) A 2-min TPEN application did not significantly reduce GPN-induced lysosomal Ca<sup>2+</sup> release in HEK293T cells. (<bold>D</bold>) Long-term TPEN treatment (20 min) abolished ER Ca<sup>2+</sup> release upon ATP stimulation and GPN-induced lysosomal Ca<sup>2+</sup> release in HEK293T cells loaded with Fura-2. (<bold>E</bold>) In HEK293T cells transfected with the IP3R-ligand binding domain with ER targeting sequence (IP3R-LBD-ER), the responses to ATP and GPN were reduced compared to un-transfected cells on the same coverslip. (<bold>F</bold>) Caffeine stimulates Ca<sup>2+</sup> release from ryanodine receptors and ATP stimulates Ca<sup>2+</sup> release from IP3Rs in HEK-GCaMP3-ML1 cells loaded with Fura-2. Panels <bold>A</bold>–<bold>C</bold> and <bold>E</bold> show the average response of 30–40 cells from one representative experiment.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.15887.011">http://dx.doi.org/10.7554/eLife.15887.011</ext-link></p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-15887-fig2-figsupp2-v2.tif"/></fig></fig-group></p><p>[Ca<sup>2+</sup>]<sub>ER</sub>, but not cytosolic Ca<sup>2+</sup>, can be chelated by <italic>N</italic>,<italic>N,N',N'-Tetrakis</italic> (2-pyridylmethyl) ethylenediamine (TPEN), a membrane-permeable metal chelator with a low affinity for Ca<sup>2+</sup> (<xref ref-type="bibr" rid="bib21">Hofer et al., 1998</xref>). Although TPEN may also enter the lysosomal lumen, the much reduced (&gt;100 fold less) Ca<sup>2+</sup>-binding affinity in the acidic pH (pH<sub>LY</sub> = 4.6) suggests that chelation of lysosomal Ca<sup>2+</sup> would be minimal. Acute application of TPEN completely blocked lysosomal Ca<sup>2+</sup> refilling (<xref ref-type="fig" rid="fig2">Figure 2F,G</xref>). A short application of TPEN also blocked ER Ca<sup>2+</sup> release stimulated by the endogenous P2Y receptor agonist ATP (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2B</xref> compared to <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2A</xref>), but not the lysosomal Fura-2 Ca<sup>2+</sup> response stimulated by GPN (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2C</xref> compared to <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2A</xref>). These findings suggest that chelation of ER Ca<sup>2+</sup> stores using TPEN had no direct effect on the naïve Ca<sup>2+</sup> store in lysosomes, but specifically and potently affected lysosomal Ca<sup>2+</sup> refilling.</p><p>The ER Ca<sup>2+</sup>store can also be genetically and chronically reduced without raising intracellular Ca<sup>2+</sup> levels by transfecting cells with the IP3R ligand-binding domain with an ER targeting sequence (IP3R-LBD-ER) (<xref ref-type="bibr" rid="bib57">Várnai et al., 2005</xref>). As expected, IP3R-LBD-ER expression decreased ATP-induced IP3R-mediated Ca<sup>2+</sup> release (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2E</xref>). Interestingly, it also reduced the GPN induced lysosomal Ca<sup>2+</sup> release in HEK293T cells (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2E</xref>). Furthermore, in HEK-GCaMP3-ML1 cells transfected with IP3R-LBD-ER, lysosomal Ca<sup>2+</sup> release was significantly reduced when compared to un-transfected cells on the same coverslip (<xref ref-type="fig" rid="fig2">Figure 2H,I</xref>). Collectively, these findings suggest that the ER, the major Ca<sup>2+</sup> store in the cell, is essential for refilling and the ongoing maintenance of lysosomal Ca<sup>2+</sup> stores, but not required for the naïve Ca<sup>2+</sup> release from lysosomes.</p><p>A functional interaction between ER and lysosome Ca<sup>2+</sup> stores was previously suggested (<xref ref-type="bibr" rid="bib18">Haller et al., 1996a</xref>; <xref ref-type="bibr" rid="bib19">1996b</xref>), but these results have been largely ignored, presumably due to the lack of specific tools required for definitive interpretation. Recent findings have shown that as endosomes mature, they increase their contact with the ER (<xref ref-type="bibr" rid="bib16">Friedman et al., 2013</xref>). Interestingly, the Ca<sup>2+</sup> released from SERCA inhibition on the ER was detected on our GCaMP3-ML1 probe (<xref ref-type="fig" rid="fig2">Figure 2B,C</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1D,F</xref>), likely due to close membrane contact between the ER and lysosomes (<xref ref-type="bibr" rid="bib15">Eden, 2016</xref>). Similar detection of ER Ca<sup>2+</sup> release by a genetically-encoded, lysosomally-targeted chameleon Ca<sup>2+</sup> sensor utilizing lysosome membrane protein Lamp1 has also been reported (<xref ref-type="bibr" rid="bib34">McCue et al., 2013</xref>). Using time-lapse confocal imaging, we found that the majority of lysosomes, marked by Lamp1-mCherry, move and traffic together with ER tubules, labeled with CFP-ER (<xref ref-type="fig" rid="fig2">Figure 2J,K</xref>). Thus, the ER could be the direct source of Ca<sup>2+</sup> to lysosomes by forming nanojunctions with them (<xref ref-type="bibr" rid="bib15">Eden, 2016</xref>).</p></sec><sec id="s2-5"><title>IP3-receptors, not ryanodine receptors, on the ER are required for Ca<sup>2+</sup> refilling of lysosomes</title><p>Ca<sup>2+</sup> release from the ER is mediated primarily by two Ca<sup>2+</sup> release channels, IP3Rs and ryanodine receptors (RYRs), both of which are expressed in HEK cells (<xref ref-type="bibr" rid="bib47">Querfurth et al., 1998</xref>; <xref ref-type="bibr" rid="bib25">Jurkovicova et al., 2008</xref>) (see also <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2F</xref>). Since IP3Rs are responsible for Ca<sup>2+</sup> transfer to mitochondria (<xref ref-type="bibr" rid="bib20">Hayashi et al., 2009</xref>), we examined whether IP3Rs on the ER were responsible for Ca<sup>2+</sup> refilling of the lysosome. Notably, Ca<sup>2+</sup> refilling of the non-naïve lysosome Ca<sup>2+</sup> store was completely blocked by Xestospongin-C (Xesto; <xref ref-type="fig" rid="fig3">Figure 3A,C</xref>), a relatively specific IP3R blocker (<xref ref-type="bibr" rid="bib44">Peppiatt et al., 2003</xref>) (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A–E</xref>). In addition, in the GPN &amp; Fura-2 assay that provides a measurement of lysosomal Ca<sup>2+</sup> release independent of ML1, blocking IP3 receptor by Xesto profoundly attenuated lysosomal Ca<sup>2+</sup> refilling in both HEK-GCaMP3-ML1 cells and non-transfected mouse embryonic fibroblasts (MEF) cells (<xref ref-type="fig" rid="fig1">Figure 1D</xref>; <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1F–J</xref>). Acute application of Xesto after allowing lysosomal Ca<sup>2+</sup> stores to refill for 5 min (hence stores are completely refilled and functionally equivalent to 'naïve' ones) also slowly (up to 10 min) reduced lysosomal Ca<sup>2+</sup> release, suggesting that constitutive lysosomal Ca<sup>2+</sup> release under resting conditions may gradually deplete lysosome Ca<sup>2+</sup> stores if refilling is prevented (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1B–E</xref>). Consistent with this hypothesis, long-term (20 min) treatment with the aforementioned ER Ca<sup>2+</sup> manipulators including TG and TPEN almost completely abolished lysosomal Ca<sup>2+</sup> release (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2D</xref>), further supporting the interpretation that ongoing constitutive Ca<sup>2+</sup> release and refilling requires ER Ca<sup>2+</sup>.<fig-group><fig id="fig3" position="float"><object-id pub-id-type="doi">10.7554/eLife.15887.012</object-id><label>Figure 3.</label><caption><title>IP3-receptors on the ER are required for lysosomal Ca<sup>2+</sup> store refilling.</title><p>(<bold>A</bold>) The IP3-receptor (IP3R) antagonist Xestospongin-C (Xesto, 10 μM) prevented Ca<sup>2+</sup> refilling of lysosomes in HEK-GCaMP3-ML1 cells (p=0.007). Note that Xesto was co-applied with ML-SA1. (<bold>B</bold>) Ryanodine (100 μM), which blocks Ryanodine receptors at high concentrations, did not block Ca<sup>2+</sup> refilling to lysosomes. Note that Ryanodine was co-applied with ML-SA1. (<bold>C</bold>) Quantification of the responses to ML-SA1 in HEK-GCaMP3-ML1 cells after treatment with Xesto, 2-APB (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1K</xref>), U73122 (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1L,M</xref>), Ryanodine (Ry), and DHBP (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2A</xref>) (<xref ref-type="supplementary-material" rid="SD3-data">Figure 3<italic>—</italic>source data 1</xref>).(<bold>D</bold>) DT40 WT cells transiently transfected with GCaMP3-ML1 show Ca<sup>2+</sup> refilling. (<bold>D’</bold>) IP3R antagonist Xesto completely blocked Ca<sup>2+</sup> refilling of lysosomes in DT40 WT cells. (<bold>E</bold>) DT40 IP3R triple KO (TKO) cells transiently transfected with GCaMP3-ML1 also show Ca<sup>2+</sup> refilling. (<bold>E’</bold>) Xesto did not block Ca<sup>2+</sup> refilling of lysosomes in IP3R-TKO cells. (<bold>F</bold>) Quantification of ML-SA1 responses with or without Xesto in WT and IP3R-TKO DT40 cells (<xref ref-type="supplementary-material" rid="SD3-data">Figure 3<italic>—</italic>source data 1</xref>). (<bold>G</bold>) Representative images showing the effects of Xesto on the recovery of ML-SA1-induced responses in HEK-ML1 stable cells loaded with OG-BAPTA-dextran. La<sup>3+</sup> was used to block external Ca<sup>2+</sup> influx that could be mediated by surface-expressed ML1 in the overexpression system (see <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2G</xref>). (<bold>H</bold>) The effects of TG and Xesto on intralysosomal Ca<sup>2+</sup> contents measured by OG-BAPTA-dextran (<xref ref-type="supplementary-material" rid="SD3-data">Figure 3<italic>—</italic>source data 1</xref>). (<bold>I</bold>) The effects of ML-SA1 on [Ca<sup>2+</sup>]<sub>Ly</sub> measured by OG-BAPTA-dextran. Panels <bold>A</bold>, <bold>B</bold>, <bold>D</bold>, <bold>D’</bold>, <bold>E</bold>, <bold>E’</bold>, <bold>F</bold>, <bold>F’</bold> and <bold>H</bold> are the average of 30–40 cells from one representative experiment. The data in panels <bold>C</bold>, <bold>F</bold> and <bold>H</bold> represent mean ± SEM from at five independent experiments. The scale bar in panel G = 10 μm.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.15887.012">http://dx.doi.org/10.7554/eLife.15887.012</ext-link></p><p><supplementary-material id="SD3-data"><object-id pub-id-type="doi">10.7554/eLife.15887.013</object-id><label>Figure 3—source data 1.</label><caption><title>Normalized ML-SA1 responses or lysosomal Ca<sup>2+</sup> contents under pharmacological (<bold>C</bold>, <bold>H</bold>) or genetic manipulations (<bold>F</bold>) (<xref ref-type="fig" rid="fig3">Figure 3C, F, H</xref>). </title><p>The effects of Xesto on GPN responses in GCaMP3-ML1 (<bold>G</bold>) and MEF cells (<bold>J</bold>) (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1G, J</xref>). ML-SA1 responses in GCaMP3-ML1-transfected WT and IP3R-TKO DT40 cells (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2B</xref>). The effects of Xesto treatment on lysosomal Ca<sup>2+</sup> changes induced by ML-SA1 (<xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3E, G</xref>).</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.15887.013">http://dx.doi.org/10.7554/eLife.15887.013</ext-link></p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-15887-fig3-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="jpeg" mimetype="image" xlink:href="elife-15887-fig3-v2.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.15887.014</object-id><label>Figure 3—figure supplement 1.</label><caption><title>ER IP3-Receptors regulate Ca<sup>2+</sup> refilling of lysosomes.</title><p>(<bold>A</bold>) Xesto application (5 min) blocked ER Ca<sup>2+</sup> release in HEK293T cells loaded with Fura-2. (<bold>B</bold>) After 5 min of refilling, which is expected to fully refill the lysosomal Ca<sup>2+</sup> stores, acute treatment of Xesto (10 μM) for 2 min did not significantly reduce lysosomal Ca<sup>2+</sup> release. Lysosomal Ca<sup>2+</sup> release was induced by ML-SA1 in HEK-GCaMP3-ML1 cells. (<bold>C</bold>) After 5 min of refilling of lysosomal Ca<sup>2+</sup> stores, subsequent acute treatment of Xesto (10 μM) for 5 min slightly reduced lysosomal Ca<sup>2+</sup> release. (<bold>D</bold>) After 5 min of refilling of lysosomal Ca<sup>2+</sup> stores, acute treatment of Xesto (10 μM) for 10 min abolished lysosomal Ca<sup>2+</sup> release. (<bold>E</bold>) Time-dependent depletion of lysosomal Ca<sup>2+</sup> stores by pharmacological inhibition of IP3-receptors. (<bold>F</bold>, <bold>G</bold>) In contrast to control (<xref ref-type="fig" rid="fig1">Figure 1C</xref>), application of Xesto dramatically reduced Fura-2 responses to GPN in GCaMP3-ML1 cells loaded with Fura-2 (<xref ref-type="supplementary-material" rid="SD3-data">Figure 3<italic>—</italic> source data 1</xref>). (<bold>H</bold>) Fura-2 Ca<sup>2+</sup> imaging of GPN responses in MEF cells. (<bold>I</bold>) Xesto application dramatically reduced the second response to GPN in MEF cells. (<bold>J</bold>) Average effects of Xesto on lysosomal Ca<sup>2+</sup> refilling in MEF cells (<xref ref-type="supplementary-material" rid="SD3-data">Figure 3<italic>—</italic>source data 1</xref>). (<bold>K</bold>) IP3R antagonist 2-APB (200 μM) blocked lysosomal Ca<sup>2+</sup> refilling (p=0.013; also see <xref ref-type="fig" rid="fig3">Figure 3C</xref>). (<bold>L</bold>) PLC inhibitor U73122 (10 μM) blocked Ca<sup>2+</sup> release from IP3Rs stimulated by ATP. (<bold>M</bold>) U73122 treatment abolished Ca<sup>2+</sup> refilling of lysosomes (p=0.0070). Panels <bold>A</bold>–<bold>D</bold>, <bold>F</bold>, <bold>H</bold>, <bold>I</bold>, <bold>K</bold>, <bold>L</bold> and <bold>M</bold> show the average response of 30–40 cells from one representative experiment.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.15887.014">http://dx.doi.org/10.7554/eLife.15887.014</ext-link></p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-15887-fig3-figsupp1-v2.tif"/></fig><fig id="fig3s2" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.15887.015</object-id><label>Figure 3—figure supplement 2.</label><caption><title>Lysosomal Ca2+ refilling is compromised in IP3R TKO DT40 cells.</title><p>(<bold>A</bold>) Ryanodine receptor blocker DHBP (50 μM) did not block Ca<sup>2+</sup> refilling of lysosomes. (<bold>B</bold>) Quantification of the 1st, 2nd and 3rd ML-SA1 responses in GCaMP3-ML1-transfected WT and IP3R-TKO DT40 cells (<xref ref-type="supplementary-material" rid="SD3-data">Figure 3<italic>—</italic>source data 1</xref>). (<bold>C</bold>) Time-dependence of lysosomal Ca<sup>2+</sup> store refilling in WT and IP3R TKO DT40 cells. (<bold>D</bold>) GCaMP3-ML1-transfected IP3R-TKO DT40 cells still showed refilling after 5 min of DHBP application to block RYRs. (<bold>E</bold>) RYR inhibitors Diltiazem (50 µM) and Dantrolene (50 µM) did not block lysosomal Ca<sup>2+</sup> refilling in GCaMP3-ML1-transfected IP3R-TKO DT40 cells. Panels <bold>A</bold>, <bold>D</bold> and <bold>E</bold> show the average response of 30–40 cells from one representative experiment.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.15887.015">http://dx.doi.org/10.7554/eLife.15887.015</ext-link></p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-15887-fig3-figsupp2-v2.tif"/></fig><fig id="fig3s3" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.15887.016</object-id><label>Figure 3—figure supplement 3.</label><caption><title>Measuring lysosomal Ca<sup>2+</sup> release with lysosome-targeted luminal Ca<sup>2+</sup> indicators.</title><p>(<bold>A</bold>) Fura-Dextran was pulse/chased into HEK293T cells transfected with Lamp1-mCherry. Fura-Dextran dyes were co-localized well with Lamp1-mCherry after 12 hr pulse and 4 hr chase, although not all lysosomes were loaded with the dye, evidenced by many Lamp1-mCherry vesicles without Fura-Dextran co-localization. Scale bar = 5 μm. (<bold>B</bold>) OG-BAPTA-dextran displayed better loading to lyssosomes and a high level of co-localization with LysoTracker. Scale bar =10 μm. (<bold>C</bold>) pH-dependence of the measured <italic>K</italic><sub>d</sub> values for OG-BAPTA-dextran. (<bold>D</bold>) Compared with the control, Xesto (25 μM) treatment for 5 min prevented Ca<sup>2+</sup> refilling to lysosomes measured with Fura-Dextran, a lysosome-targeted luminal Ca<sup>2+</sup> indicator. Right panels show the zoom-in images of ML-SA1-induced responses before and after Xesto treatment. (<bold>E</bold>) Quantification of ML-SA1 responses with or without Xesto in cells loaded with Fura-Dextran. Xesto significantly (p=0.026) blocked refilling as shown by no response to ML-SA1 after Xesto application during refilling (n=3; <xref ref-type="supplementary-material" rid="SD3-data">Figure 3<italic>—</italic> source data 1</xref>). (<bold>F</bold>) Representative images showing the effect of TG treatment on the recovery of ML-SA1-induced responses in OG-BAPTA-dextran loaded HEK-ML1 stable cells. (<bold>G</bold>) Average effects of TG on lysosomal Ca<sup>2+</sup> refilling in OG-BAPTA-dextran loaded HEK-ML1 cells. Lysosomal Ca<sup>2+</sup> release was induced by ML-SA1 in zero Ca<sup>2+</sup> external solution (<xref ref-type="supplementary-material" rid="SD3-data">Figure 3<italic>—</italic>source data 1</xref>). (<bold>H</bold>) The effects of TG treatment on intra-lysosomal Ca<sup>2+</sup> levels, measured by OG-BAPTA-dextran imaging. (<bold>I</bold>) A calibration curve for the pH-sensitive dye OG-488-dextran. (<bold>J</bold>, <bold>K</bold>) Baf-A1 (5 μM; <bold>J</bold>) and NH<sub>4</sub>Cl (10 mM; <bold>K</bold>) induced changes in both lysosomal pH and OG-BAPTA-dextran fluorescence.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.15887.016">http://dx.doi.org/10.7554/eLife.15887.016</ext-link></p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-15887-fig3-figsupp3-v2.tif"/></fig></fig-group></p><p>2-APB, a non-specific IP3R antagonist (<xref ref-type="bibr" rid="bib44">Peppiatt et al., 2003</xref>), also blocked Ca<sup>2+</sup> refilling (<xref ref-type="fig" rid="fig3">Figure 3C</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1K</xref>). U73122 is a PLC inhibitor that blocks the constitutive production of IP3 (<xref ref-type="bibr" rid="bib11">Cárdenas et al., 2010</xref>) and prevents ATP-induced IP3R-mediated Ca<sup>2+</sup> release (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1L</xref>). U73122 also completely prevented Ca<sup>2+</sup> refilling of lysosomes (<xref ref-type="fig" rid="fig3">Figure 3C</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1M</xref>), suggesting that basal production of IP3 is essential for Ca<sup>2+</sup> refilling of lysosomes. In contrast, blocking the RyRs with high (&gt;10 μM) concentrations of ryanodine (<xref ref-type="fig" rid="fig3">Figure 3B,C</xref>), or with the receptor antagonist 1,1′-diheptyl-4,4′-bipyridinium (DHBP) (<xref ref-type="bibr" rid="bib4">Berridge, 2012</xref>) (<xref ref-type="fig" rid="fig3">Figure 3C</xref>, <xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2A</xref>), did not affect Ca<sup>2+</sup> refilling. Notably, co-application of RYR and IP3R blockers with the second ML-SA1 response did not change the amplitude of the response (<xref ref-type="fig" rid="fig3">Figure 3A,B</xref>). Together, these findings demonstrate that IP3Rs on the ER are specifically required for lysosomal Ca<sup>2+</sup> refilling, but not for Ca<sup>2+</sup> release from naïve stores or completely refilled stores.</p><p>In contrast with the pharmacological analyses described above, lysosomal store refilling occurred in both WT and IP3R triple KO (TKO) DT40 chicken B cells (<xref ref-type="bibr" rid="bib57">Várnai et al., 2005</xref>; <xref ref-type="bibr" rid="bib11">Cárdenas et al., 2010</xref>) that were transfected with GCaMP3-ML1 (<xref ref-type="fig" rid="fig3">Figure 3D–F</xref>, <xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2B</xref>). However, unlike WT DT40 cells, in which the IP3R-specific antagonist Xesto completely blocked Ca<sup>2+</sup> refilling (<xref ref-type="fig" rid="fig3">Figure 3D’, F</xref>), Xesto had no obvious blocking effect in IP3R-TKO cells (<xref ref-type="fig" rid="fig3">Figure 3E’, F</xref>). In addition, the kinetics of lysosomal refilling was markedly delayed in IP3R TKO cells compared with WT cells (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2C</xref>). These results are consistent with the notion that in normal conditions, IP3Rs are the sole source of Ca<sup>2+</sup> refilling of lysosomes. When IP3Rs are genetically deleted, however, IP3R-independent mechanisms contribute to lysosomal Ca<sup>2+</sup> refilling, possibly as a consequence of genetic compensation. Refilling in IP3R-TKO DT40 cells was not blocked by RYR inhibitors (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2D,E</xref>).</p></sec><sec id="s2-6"><title>Studying lysosomal Ca<sup>2+</sup> refilling using intra-lysosomal Ca<sup>2+</sup> dyes</title><p>As an additional assay to directly 'monitor' intralysosomal Ca<sup>2+</sup>, we employed two intraluminal Ca<sup>2+</sup> indicators Fura-Dextran and Oregon 488 BAPTA-1 dextran (OG-BAPTA-dextran) (<xref ref-type="bibr" rid="bib39">Morgan et al., 2015</xref>). After being pulse/chased into ML1-mCherry-transfected HEK293T cells or HEK-ML1 stable cells, the dyes enter the lysosome lumen (<xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3A,B</xref>) after endocytosis (<xref ref-type="bibr" rid="bib8">Christensen et al., 2002</xref>). Due to their pH sensitivities, these dyes can detect intra-lysosomal Ca<sup>2+</sup> ([Ca<sup>2+</sup>]<sub>LY</sub>) changes, but preferentially only when the intra-lysosomal pH (pH<sub>L</sub>) remains constant below pH 5.0 (<xref ref-type="bibr" rid="bib39">Morgan et al., 2015</xref>) (see <xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3C</xref>). In the Fura-Dextran-loaded ML1-mCherry-transfected HEK-293T cells, ML-SA1 application induced Ca<sup>2+</sup> release from the lysosome lumen (<xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3D</xref>). As we found in our GCaMP3-ML1 assay, Xesto abolished the ML-SA1-induced decrease in [Ca<sup>2+</sup>]<sub>LY</sub>(<xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3D,E</xref>). Likewise, in HEK-ML1 stable cells loaded with OG-BAPTA-dextran, which had a much higher efficiency in loading to the lysosome (<xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3B</xref>), TG or Xesto treatment profoundly reduced lysosomal Ca<sup>2+</sup> refilling (<xref ref-type="fig" rid="fig3">Figure 3G—I</xref>; <xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3F,G</xref>). Note that LysoTracker staining was not significantly reduced by ML-SA1, TG, or Xesto, suggesting that the signals were primarily mediated by changes of intralysosomal Ca<sup>2+</sup>, not intralysosomal pH. In contrast, treatment of cells with Baf-A1 or NH<sub>4</sub>Cl markedly increased lysosomal pH from 4.8 to 7.0 (<xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3J,K</xref>). Such large pH elevations may cause dramatic changes in both <italic>K</italic><sub>d</sub> of OG-BAPTA-dextran (see <xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3C</xref>) and luminal Ca<sup>2+</sup> buffering capability (<xref ref-type="bibr" rid="bib39">Morgan et al., 2015</xref>; <xref ref-type="bibr" rid="bib12">Dickson et al., 2012</xref>), preventing accurate determinations of [Ca<sup>2+</sup>]<sub>LY</sub> under these pH manipulations. Taken together, these results are consistent with the conclusions that were drawn based on the aforementioned ML-SA1 &amp; GCaMP3-ML1 assay and the GPN &amp; Fura-2 assay.</p></sec><sec id="s2-7"><title>Inhibition of ER IP3R channels and Ca<sup>2+</sup> release causes lysosomal dysfunction and a LSD-like phenotype</title><p>Lysosomal Ca<sup>2+</sup> is important to lysosomal function and membrane trafficking (<xref ref-type="bibr" rid="bib28">Kiselyov et al., 2010</xref>; <xref ref-type="bibr" rid="bib53">Shen et al., 2012</xref>; <xref ref-type="bibr" rid="bib31">Lloyd-Evans et al., 2008</xref>). Lysosomal dysfunction is commonly associated with a compensatory increase of lysosome biogenesis, manifested as increased expression of essential lysosomal genes (<xref ref-type="bibr" rid="bib52">Settembre et al., 2013</xref>). For example, the expression of Lamp1, a lysosomal marker, is elevated in most LSDs (<xref ref-type="bibr" rid="bib36">Meikle et al., 1997</xref>). Lamp1 expression was significantly elevated in cells treated with low concentrations of IP3R blockers 2-APB and Xesto, as well as the ER Ca<sup>2+</sup> chelator TPEN, but not in the cells treated with the RyR blocker DHBP (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). Consistently, LysoTracker staining was significantly increased in cells treated with Xesto, but not 1,1'-diheptyl-4,4'-bipyridinium dibromide (DHBP; <xref ref-type="fig" rid="fig4">Figure 4B</xref>). Lysosomal dysfunction is also often associated with lysosomal enlargement and accumulation of various incompletely digested biomaterials (<xref ref-type="bibr" rid="bib53">Shen et al., 2012</xref>; <xref ref-type="bibr" rid="bib13">Dong et al., 2008</xref>). Notably, in cells that were treated with Xesto, but not with the vehicle control DMSO, lysosomal compartments were enlarged, and non-degradable, autofluorescent lipofuscin-like materials accumulated in puncta structures (<xref ref-type="fig" rid="fig4">Figure 4C</xref>), reminiscent of cells with defective lysosomal Ca<sup>2+</sup> release (ML1 KO cells; <xref ref-type="bibr" rid="bib13">Dong et al., 2008</xref>) (<xref ref-type="fig" rid="fig4">Figure 4C</xref>). By showing that inhibiting IP3R-mediated Ca<sup>2+</sup> release from the ER results in a lysosome storage phenotype in the cell, these findings suggest that lysosome Ca<sup>2+</sup> store refilling from IP3Rs ion the ER has important consequences for lysosome function and cellular health.<fig id="fig4" position="float"><object-id pub-id-type="doi">10.7554/eLife.15887.017</object-id><label>Figure 4.</label><caption><title>Blocking ER IP3-receptors Ca<sup>2+</sup> channels refill lysosome Ca<sup>2+</sup> stores to prevent lysosomal dysfunction.</title><p>(<bold>A</bold>) Upper panels: Western blotting analyses of Lamp1 in HEK293T cells treated with 2-APB (50 μM), TPEN (0.1 μM), Xesto (10 μM), and DHBP (5 μM) compared to DMSO for 24 hr (n=4 separate experiments for each condition). Lower panel: treating HEK293T cells with 2-APB (p=0.05) and Xesto (p=0.013), as well as TPEN (p=0.02), significantly increased Lamp1 expression. DHBP did not significantly change Lamp1 expression (p=0.23) (<xref ref-type="supplementary-material" rid="SD4-data">Figure 4<italic>—</italic>source data 1</xref>). (<bold>B</bold>) The effects of Xesto (10 μM, 18 hr; p=0.0001) and DHBP (50 μM, 18 hr; p=0.063) treatment compared to DMSO on the lysosomal compartments detected by LysoTracker staining in HEK293T cells (average of 20–30 cells in each of 3 experiments; <xref ref-type="supplementary-material" rid="SD4-data">Figure 4<italic>—</italic>source data 1</xref>). Scale bar = 15 μm. (<bold>C</bold>) The effect of Xesto (10 μM, 18 h) treatment on accumulation of the autofluorescent lipofuscin materials in non-transfected HEK293T cells. Autofluorescence was observed in a wide spectrum but shown at two excitation wavelengths (488 and 561 nm). ML1 KO MEFs are shown for comparison. Scale bar = 15 μm. (<bold>D</bold>) A proposed model of Ca<sup>2+</sup> transfer from the ER to lysosomes. The ER is a Ca<sup>2+</sup> store with [Ca<sup>2+</sup>]<sub>ER</sub> ~ 0.3–0.7 mM; lysosomes are acidic (pH<sub>Ly</sub> ~ 4.6) Ca<sup>2+</sup> stores ([Ca<sup>2+</sup>]<sub>Ly</sub> ~ 0.5 mM). IP3Rs on the ER release Ca<sup>2+</sup> to produce a local high Ca<sup>2+</sup> concentration, from which an unknown low-affinity Ca<sup>2+</sup> transport mechanism refills Ca<sup>2+</sup> to a lysosome. Unidentified tether proteins may link the ER membrane proteins directly with the lysosomal membrane proteins to maintain contact sites of 20–30 nm for purposes of Ca<sup>2+</sup> exchange. Ca<sup>2+</sup> released from lysosomes or a reduction/depletion in [Ca<sup>2+</sup>]<sub>Ly</sub> may, through unidentified mechanisms, 'promote' or 'stabilize' ER-lysosome interaction (<xref ref-type="bibr" rid="bib45">Phillips and Voeltz, 2016</xref>; <xref ref-type="bibr" rid="bib15">Eden, 2016</xref>). At the functional ER-lysosome contact sites, Ca<sup>2+</sup> can be transferred from the ER to lysosomes through a passive Ca<sup>2+</sup> transporter or channel based on the large chemical gradient of Ca<sup>2+</sup> that is created when lysosome stores are depleted. Baf-A and Con-A are specific V-ATPase inhibitors; Xesto and 2APB are IP3R blockers; U73122 is a PLC inhibitor that blocks the constitutive production of IP3; DHBP and Ryanodine (&gt;10 μM) are specific RyR blockers; TG and CPA are SERCA pump inhibitors; and TPEN is a luminal Ca<sup>2+</sup> chelator.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.15887.017">http://dx.doi.org/10.7554/eLife.15887.017</ext-link></p><p><supplementary-material id="SD4-data"><object-id pub-id-type="doi">10.7554/eLife.15887.018</object-id><label>Figure 4—source data 1.</label><caption><title>Source data of <xref ref-type="fig" rid="fig4">Figure 4A,B</xref>: Quantifications of Lamp-1 protein levels (<bold>A</bold>) or LysoTracker staining (<bold>B</bold>) under different experimental conditions and manipulations.</title><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.15887.018">http://dx.doi.org/10.7554/eLife.15887.018</ext-link></p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-15887-fig4-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="jpeg" mimetype="image" xlink:href="elife-15887-fig4-v2.tif"/></fig></p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Using pharmacological and genetic approaches to manipulate ER Ca<sup>2+</sup> levels and Ca<sup>2+</sup> release and three different assays to directly measure lysosome Ca<sup>2+</sup> release, we show that under normal conditions lysosome Ca<sup>2+</sup> stores are refilled from the ER Ca<sup>2+</sup> store through IP3 receptors independent of lysosome pH (see <xref ref-type="fig" rid="fig4">Figure 4D</xref>). Our findings are in contrast to several studies in the literature that suggest that inhibition of the V-ATPase is sufficient to deplete lysosome Ca<sup>2+</sup> stores. Previous conclusions suggesting the importance of H<sup>+</sup> gradient in regulating lysosome Ca<sup>2+</sup> stores would therefore implicate the existence of an H<sup>+</sup>-dependent Ca<sup>2+</sup> transporter in lysosomal membranes that can operate at the extremely low cytosolic free Ca<sup>2+</sup> level (100 nM), representing a high affinity uptake system. Our work, however, suggest that a low affinity uptake mechanism is more likely. Hence either a low affinity Ca<sup>2+</sup> transporter or rectifying Ca<sup>2+</sup> channel might suffice. A putative VDAC-like channel in the lysosome, resembling mitochondrial VDAC channels (<xref ref-type="bibr" rid="bib56">van der Kant and Neefjes, 2014</xref>), may interact directly with IP3Rs to receive Ca<sup>2+</sup> from the ER. Importantly, it has been previously suggested that Ca<sup>2+</sup> uptake into isolated lysosomes is mediated by a low-affinity (mM range) Ca<sup>2+</sup> transporter (<xref ref-type="bibr" rid="bib29">Lemons and Thoene, 1991</xref>).</p><p>The lysosomal pH gradient is thought to be essential for the maintenance of high free [Ca<sup>2+</sup>]<sub>Ly</sub> (<xref ref-type="bibr" rid="bib6">Calcraft et al., 2009</xref>; <xref ref-type="bibr" rid="bib8">Christensen et al., 2002</xref>; <xref ref-type="bibr" rid="bib12">Dickson et al., 2012</xref>; <xref ref-type="bibr" rid="bib31">Lloyd-Evans et al., 2008</xref>; <xref ref-type="bibr" rid="bib53">Shen et al., 2012</xref>). However, in addition to triggering lysosomal Ca<sup>2+</sup> release, as proposed by Christensen et al. (<xref ref-type="bibr" rid="bib8">Christensen et al., 2002</xref>), lysosomal pH elevation is also known to affect [Ca<sup>2+</sup>]<sub>Ly</sub> or its measurement via several other mechanisms. Whereas the total [Ca<sup>2+</sup>]<sub>Ly</sub> is reported to be in the low mM range (5–10 mM), free [Ca<sup>2+</sup>]<sub>Ly</sub> is generally agreed to be in the high μM range (100–500 μM) (<xref ref-type="bibr" rid="bib39">Morgan et al., 2015</xref>). Therefore, the lysosome lumen must contain substantial Ca<sup>2+</sup> buffers (<xref ref-type="bibr" rid="bib39">Morgan et al., 2015</xref>). Ca<sup>2+</sup> buffers in acidic compartments and the ER are known to bind Ca<sup>2+</sup> much better at neutral pH (<xref ref-type="bibr" rid="bib12">Dickson et al., 2012</xref>). Hence increasing pH<sub>L</sub> from 4.8 to 7.0 may effectively reduce free [Ca<sup>2+</sup>]<sub>Ly</sub> without necessarily triggering lysosomal Ca<sup>2+</sup> release and affecting total [Ca<sup>2+</sup>]<sub>Ly</sub>. Consistent with such an interpretation, a compelling study recently demonstrated that in secretory granules and the ER, increasing luminal pH changed the Ca<sup>2+</sup> buffering capacity of both Ca<sup>2+</sup> containing compartments and reduced free [Ca<sup>2+</sup>], while causing a minimal (20 nM) increase in cytosolic Ca<sup>2+</sup> (<xref ref-type="bibr" rid="bib12">Dickson et al., 2012</xref>). Additionally, lysosomal pH may act on luminal Ca<sup>2+</sup> dyes by affecting their chromophore fluorescence and Ca<sup>2+</sup>-binding affinity (<italic>K</italic><sub>d</sub>) (<xref ref-type="bibr" rid="bib39">Morgan et al., 2015</xref>). Because <italic>K</italic><sub>d</sub> drops more than 1,000 foldtimes when pH<sub>L</sub> is increased from 4.8 to 7.0, accurate calibration is currently not possible. Furthermore, prolonged lysosomal pH manipulations may also indirectly affect lysosomal Ca<sup>2+</sup> homeostasis, for instance, via membrane fusion and fission between compartments containing different amounts of Ca<sup>2+</sup>, H<sup>+</sup>, and their buffers. Finally, although elevating lysosomal pH may trigger lysosomal Ca<sup>2+</sup> release, the accompanying increase in cytoplasmic Ca<sup>2+</sup> was rather small (20–40 nM) (<xref ref-type="bibr" rid="bib12">Dickson et al., 2012</xref>; <xref ref-type="bibr" rid="bib8">Christensen et al., 2002</xref>). Moreover, the instantaneous changes (following pH increase and decrease) of Ca<sup>2+</sup> probe fluorescence (<xref ref-type="bibr" rid="bib12">Dickson et al., 2012</xref>; <xref ref-type="bibr" rid="bib8">Christensen et al., 2002</xref>) are inconsistent with the slow rates of Ca<sup>2+</sup> leak and re-uptake demonstrated in the current study.</p><p>The persistence of a GPN signal even after intracellular Ca<sup>2+</sup> chelation is important for understanding the limits of this lysosome-specific pharmacological tool. GPN can certainly be used in conjunction with other tools to examine lysosome specificity, but caution is necessary with its use for Ca<sup>2+</sup> store measurement, as a component of the signal observed in Fura-2 loaded cells, although small, is a result of the membrane permeabilization that causes a decrease in cytosolic pH. Similarly, reagents like Baf-A and NAADP that are used to mobilize lysosomal Ca<sup>2+</sup> also release H<sup>+</sup> into the cytosol (<xref ref-type="bibr" rid="bib40">Morgan and Galione, 2007</xref>; <xref ref-type="bibr" rid="bib2">Appelqvist et al., 2012</xref>; <xref ref-type="bibr" rid="bib51">Scott and Gruenberg, 2011</xref>; <xref ref-type="bibr" rid="bib61">Yoshimori et al., 1991</xref>), which could have been misinterpreted as a Ca<sup>2+</sup> signal in previous studies (<xref ref-type="bibr" rid="bib41">Morgan et al., 2011</xref>). pH may affect cytosolic Ca<sup>2+</sup> indicators through the chromophore fluorescence, Ca<sup>2+</sup>-binding affinity, or Ca<sup>2+</sup>-dependent conformational changes (e.g., in the case of GCaMP) (<xref ref-type="bibr" rid="bib39">Morgan et al., 2015</xref>). Therefore, if experimental conditions are not optimized, the presumed cytosolic Ca<sup>2+</sup> signals may also reflect pH changes, or unidentified pH-mediated non-Ca<sup>2+</sup> signals. We propose that BAPTA-AM control experiments be routinely conducted in any lysosomal Ca<sup>2+</sup> measurement. It is possible that the 'pH contaminating effect' might have resulted in numerous misinterpretations of lysosome Ca<sup>2+</sup> stores in the literature, particularly those examining the interactions between ER and lysosome Ca<sup>2+</sup>.</p><p>Based on our results in the current study, recent studies of ER-lysosome interactions (<xref ref-type="bibr" rid="bib45">Phillips and Voeltz, 2016</xref>), and previous Ca<sup>2+</sup> uptake studies on isolated lysosomes (<xref ref-type="bibr" rid="bib29">Lemons and Thoene, 1991</xref>), we hypothesize that ER-refilling of lysosomal stores is a regulated, two-step process (see <xref ref-type="fig" rid="fig4">Figure 4D</xref>). First, lysosome store depletion may trigger establishment of ER-lysosome contacts (<xref ref-type="bibr" rid="bib45">Phillips and Voeltz, 2016</xref>). Although lysosomes and ER are in close proximity under resting conditions, lysosome store depletion may 'stabilize' the ER-lysosome contact, and/or 'tether' and approximate both membranes (e.g., from 20–30 nm to 10 nm) (<xref ref-type="bibr" rid="bib45">Phillips and Voeltz, 2016</xref>; <xref ref-type="bibr" rid="bib15">Eden, 2016</xref>). Second, at the relatively stable, functional ER-lysosome contact sites, a passive Ca<sup>2+</sup> transport process can occur from the ER to lysosomes, by utilizing the large Ca<sup>2+</sup>gradient created when lysosome stores are actively depleted. Up to 5 min may be required to complete the whole refilling process from 'initiation' through 'uptake'.</p><p>Our results not only provide an explanation for the reported sensitivity of the Ca<sup>2+</sup> stores of acidic organelles to ER disrupting agents (<xref ref-type="bibr" rid="bib37">Menteyne et al., 2006</xref>; <xref ref-type="bibr" rid="bib18">Haller et al., 1996a</xref>), but are also consistent with the observations that lysosomes may buffer cytosolic Ca<sup>2+</sup> released from the ER (<xref ref-type="bibr" rid="bib32">López-Sanjurjo et al., 2013</xref>). The unexpected role of the ER in maintaining Ca<sup>2+</sup> stores in lysosomes may help resolve the long-standing mystery of how impaired ER Ca<sup>2+</sup> homeostasis is commonly seen in lysosomal storage diseases (LSDs) (<xref ref-type="bibr" rid="bib10">Coen et al., 2012</xref>), and how manipulating ER Ca<sup>2+</sup> reduces lysosome storage (<xref ref-type="bibr" rid="bib31">Lloyd-Evans et al., 2008</xref>; <xref ref-type="bibr" rid="bib42">Mu et al., 2008</xref>). In addition, our work reveals that, depending on the treatment conditions (acute <italic>versus</italic> prolonged treatment), many assumed-to-be ER-specific reagents may indirectly affect lysosome Ca<sup>2+</sup> stores. This may impact the interpretations of a large body of literature on Ca<sup>2+</sup> signaling. Although we demonstrated a central role of IP3Rs in lysosomal Ca<sup>2+</sup> refilling, other ER Ca<sup>2+</sup> channels may also participate under certain conditions, as seen in the IP3R TKO cells.</p><p>Accumulating evidence suggests that the ER forms membrane contact sites with other organelles, including plasma membrane, mitochondria (<xref ref-type="bibr" rid="bib11">Cárdenas et al., 2010</xref>), endosomes (<xref ref-type="bibr" rid="bib1">Alpy et al., 2013</xref>), and lysosomes (<xref ref-type="bibr" rid="bib56">van der Kant and Neefjes, 2014</xref>). ER-endosome membrane contact, although currently difficult to study, was proposed to facilitate cholesterol transport from endosomes to the ER (<xref ref-type="bibr" rid="bib49">Rocha et al., 2009</xref>; <xref ref-type="bibr" rid="bib56">van der Kant and Neefjes, 2014</xref>; <xref ref-type="bibr" rid="bib14">Drin et al., 2016</xref>). Given the established role of lysosomal Ca<sup>2+</sup> release in cholesterol transport (<xref ref-type="bibr" rid="bib53">Shen et al., 2012</xref>), lysosomal Ca<sup>2+</sup> release may have a direct role in regulating ER-lysosome interaction (see <xref ref-type="fig" rid="fig4">Figure 4D</xref>). In ER-mitochondria contact sites, the tethering protein GRP-75 links IP3Rs with VDAC channels on mitochondria to regulate Ca<sup>2+</sup> homeostasis and ATP production (<xref ref-type="bibr" rid="bib11">Cárdenas et al., 2010</xref>). Similar unidentified tethers may also link IP3Rs with the putative lysosomal Ca<sup>2+</sup> transporter for store refilling (see <xref ref-type="fig" rid="fig4">Figure 4D</xref>). The importance of lysosomal Ca<sup>2+</sup> in regulating a variety of intracellular signaling pathways is becoming increasingly recognized (<xref ref-type="bibr" rid="bib35">Medina et al., 2015</xref>). ER-lysosome interaction may serve as a hub for Ca<sup>2+</sup> signaling to regulate cellular homeostasis through coordinating the primary anabolic and catabolic pathways in the cell. Studying the two-step lysosomal Ca<sup>2+</sup> refilling process may prove important for future identification of the low-affinity Ca<sup>2+</sup> uptake transporter/channel in the lysosome, and for studying the molecular mechanisms that regulate the functional ER-lysosome interaction.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Molecular biology</title><p>Genetically-encoded Ca<sup>2+</sup> indicator GCaMP3 was fused directly to the N-terminus of ML1 (GCaMP3-ML1) as described previously (<xref ref-type="bibr" rid="bib53">Shen et al., 2012</xref>). The IP3R-LBD-ER construct (<xref ref-type="bibr" rid="bib57">Várnai et al., 2005</xref>) was a kind gift from Dr. Thomas Balla (National Institute of Child Health and Human Development, NIH). The pECFP-ER plasmid was obtained from CLONTECH. Lamp1-mCherry was made by fusing mCherry with the C terminus of Lamp1.</p></sec><sec id="s4-2"><title>Western blotting</title><p>Standard Western blotting protocols were used. HEK293T cells were treated every 4 hr for 24 hr with IP3R antagonists 2-APB and Xestospongin-C, ER Ca<sup>2+</sup> chelator TPEN, and RyR antagonist DHBP. Lamp1 antibody was from Developmental Studies Hybridoma Bank (Iowa).</p></sec><sec id="s4-3"><title>Mammalian cell culture</title><p>Immortalized cell lines (HEK293 and Cos-7) were purchased from ATCC and cultured following standard culture protocols. DT40-WT and IP3R-TKO cells were a generous gift from Dr. Darren Boehning (The University of Texas Health Sciences Center at Houston). Human fibroblasts were obtained from the Cornell Institute for Medical Research (NJ, USA). HEK 293 cells stably expressing GCaMP3-ML1 (HEK-GCaMP3-ML1 cells) were generated using the Flip-In T-Rex 293 cell line (Invitrogen). All these cells were neither authenticated nor tested for mycoplasma contamination. HEK293 cells are on the list of frequently misidentified or cross-contaminated cell lines. All cells were cultured in a 37°C incubator with 5% CO<sub>2</sub>. HEK293T cells, Tet-On HEK293 cells stably expressing GCaMP3-ML1 (HEK-GCaMP3-ML1 cells), Cos-7 cells, and human fibroblasts were cultured in DMEM F12 (Invitrogen) supplemented with 10% (vol/vol) FBS or Tet-free FBS. DT40 cells were kept in suspension in RPMI 1640 (Invitrogen) supplemented with 450 µL β-mercaptoethanol, 2 mM L-glutamine, 10% FBS, and 1% chicken serum (<xref ref-type="bibr" rid="bib57">Várnai et al., 2005</xref>; <xref ref-type="bibr" rid="bib11">Cárdenas et al., 2010</xref>). We noted that lysosomal Ca<sup>2+</sup> store refilling was often compromised in high-passage or poorly-maintained cell cultures.</p><p>Human fibroblasts and DT40 cells were transiently transfected using the Invitrogen Neon electroporation kit (1200 V, 1 pulse, 30 s). HEK293T cells, HEK-GCaMP3-ML1 cells, and Cos-7 cells were transfected using Lipofectamine 2000 (Invitrogen). All cells were used for experiments 24–48 hr after transfection.</p></sec><sec id="s4-4"><title>Confocal imaging</title><p>Live imaging of cells was performed on a heated and humidified stage using a Spinning Disc Confocal Imaging System. The system includes an Olympus IX81 inverted microscope, a 100X Oil objective NA 1.49 (Olympus, UAPON100XOTIRF), a CSU-X1 scanner (Yokogawa), an iXon EM-CCD camera (Andor). MetaMorph Advanced Imaging acquisition software v.7.7.8.0 (Molecular Devices) was used to acquire and analyze all images. LysoTracker (50 nM; Invitrogen) was dissolved in culture medium and loaded into cells for 30 min before imaging. MitoTracker was dissolved in culture medium and loaded into cells for 15 min before imaging (25 nM). Coverslips were washed 3 times with Tyrode’s and imaged in Tyrode’s.</p></sec><sec id="s4-5"><title>GCaMP3-ML1 Ca<sup>2+</sup> imaging</title><p>GCaMP3-ML1 expression was induced in Tet-On HEK-GCaMP3-ML1 cells 20-24h prior to experiments using 0.0 1µg/mL doxycycline. GCaMP3-ML1 fluorescence was monitored at an excitation wavelength of 470 nm (F<sub>470</sub>) using a EasyRatio Pro system (PTI). Cells were bathed in Tyrode’s solution containing 145 mM NaCl, 5 mM KCl, 2 mM CaCl<sub>2</sub>, 1 mM MgCl<sub>2</sub>, 10 mM Glucose, and 20 mM Hepes (pH 7.4). Lysosomal Ca<sup>2+</sup> release was measured in a zero Ca<sup>2+</sup> solution containing 145 mM NaCl, 5 mM KCl, 3 mM MgCl<sub>2</sub>, 10 mM glucose, 1 mM EGTA, and 20 mM HEPES (pH 7.4). Ca<sup>2+</sup> concentration in the nominally free Ca<sup>2+</sup> solution is estimated to be 1–10 μM. With 1 mM EGTA, the free Ca<sup>2+</sup> concentration is estimated to be &lt;10 nM based on the Maxchelator software (<ext-link ext-link-type="uri" xlink:href="http://maxchelator.stanford.edu/">http://maxchelator.stanford.edu/</ext-link>). Experiments were carried out 0.5 to 6 hr after plating. Because baseline may drift during the entire course of the experiment (up to 20 min), we typically set F<sub>0</sub> based on the value that is closest to the baseline.</p></sec><sec id="s4-6"><title>Fura-2 Ca<sup>2+</sup> imaging</title><p>Cells were loaded with Fura-2 (3 µM) and Plurionic-F127 (3 µM) in the culture medium at 37°C for 60 min. Florescence was recorded using the EasyRatio Pro system (PTI) at two different wavelengths (340 and 380 nm) and the ratio (F<sub>340</sub>/F<sub>380</sub>) was used to calculate changes in intracellular [Ca<sup>2+</sup>]. All experiments were carried out 1.5 to 6 hr after plating.</p></sec><sec id="s4-7"><title>Oregon green 488 BAPTA-1 dextran imaging</title><p>Cells were loaded with Oregon Green 488 BAPTA-1 dextran (100 μg/ml) at 37°C in the culture medium for 4–12 hr, and then pulsed/chased for additional 4–16 hr. Fluorescence imaging was performed at 37°C. In vitro calcium-binding (<italic>K</italic><sub>d</sub>) affinities of OG-BAPTA-dextran were determined using KCl-based solutions (140 mM KCl, X mM CaCl<sub>2</sub>, 1 mM MgCl<sub>2</sub>, 10 mM HEPES, 10 mM MES, 0 or 1 mM BAPTA) adjusted to different pH (pH 4.5, 5.0, 6.0, and 7.0). By varying the amount of added Ca<sup>2+</sup> (X= 0- 10 mM), solutions with different pH and free [Ca<sup>2+</sup>] were made based on the Maxchelator software (<ext-link ext-link-type="uri" xlink:href="http://maxchelator.stanford.edu/">http://maxchelator.stanford.edu/</ext-link>). OG-BAPTA-dextran (5 μg/ml) fluorescence for each solution was obtained to plot the calibration curve (<xref ref-type="bibr" rid="bib39">Morgan et al., 2015</xref>; <xref ref-type="bibr" rid="bib12">Dickson et al., 2012</xref>; <xref ref-type="bibr" rid="bib8">Christensen et al., 2002</xref>). In cells that were pre-treated with ionomycin, nigericin, and valinomycin (<xref ref-type="bibr" rid="bib39">Morgan et al., 2015</xref>; <xref ref-type="bibr" rid="bib12">Dickson et al., 2012</xref>; <xref ref-type="bibr" rid="bib8">Christensen et al., 2002</xref>), in vivo minimal and maximal Fluorescence (F<sub>min</sub> and F<sub>max</sub>) were determined by perfusing the cells with 0 or 10 mM Ca<sup>2+</sup> external solutions, respectively. Lysosomal [Ca<sup>2+</sup>] at different pH were determined using the following calibration equation: [Ca<sup>2+</sup>] = <italic>K</italic><sub>d</sub> × (F-F<sub>min</sub>)/ (F<sub>max</sub>-F).</p></sec><sec id="s4-8"><title>Lysosomal pH measurement</title><p>Cells were pulsed with OG-488-dextran for 6 hr, and chased for additional 12 hr (<xref ref-type="bibr" rid="bib24">Johnson et al., 2016</xref>). Cells were then bathed in the external solutions (145 mM KCl, 5 mM glucose, 1 mM MgCl<sub>2</sub>, 1 mM CaCl<sub>2</sub>, 10 mM HEPES, 10 mM MES, adjusted to various pH values ranging from 4.0 to 8.0) that contained 10 μM nigericin and 10 μM monensin (<xref ref-type="bibr" rid="bib24">Johnson et al., 2016</xref>). Images were captured using an EasyRatio Pro system. A pH standard curve was plotted based on the fluorescence ratios: F<sub>480</sub>/ F<sub>430</sub>.</p></sec><sec id="s4-9"><title>Cytosolic pH sensitivity of GCaMP3-ML1</title><p>GCaMP3-ML1-positive vacuoles were isolated from vacuolin-1-treated HEK-GCaMP3-ML1 cells, as described previously (<xref ref-type="bibr" rid="bib58">Zhang et al., 2012</xref>). Briefly, cells were treated with 1 μM vacuolin-1 for up to 12 hr to increase the size of late endosomes and lysosomes (<xref ref-type="bibr" rid="bib7">Cerny et al., 2004</xref>). Vacuoles were released into the dish by mechanical disruption of the cell membrane with a small glass electrode. After vacuoles were released into the dish, patch pipettes containing either a 'high-Ca<sup>2+</sup>' (10 mM) internal solution or a 'low-pH' solution (140 mM KCl, 1 mM EGTA, 20 mM MES, 10 mM Glucose, pH adjusted to 2.0) were placed close to 'puff' the vacuoles. Images were captured using a CCD camera connected to the fluorescence microscope.</p></sec><sec id="s4-10"><title>Reagents</title><p>All reagents were dissolved and stored in DMSO or water and then diluted in Tyrode’s and 0 Ca<sup>2+</sup> solutions for experiments. 2-APB, ATP, Con-A, CPA, Doxycycline, DHBP, TG, TPEN were from Sigma; GPN and U73122 were from Santa Cruz; Ryanodine was from Abcam; LysoTracker, Fura-2, Mitotracker, Plurionic F-127, and Fura-Dextran were from Invitrogen; Baf-A was from LC Laboratories; ML-SA1 was from Chembridge; and Xestospongin-C was from Cayman Chemical, AG Scientific, and Enzo; Oregon Green 488 BAPTA-1 dextran was from life technologies. ML-SI compounds were identified from a Ca<sup>2+</sup>-imaging-based highthroughput screening conducted at NIH/NCATS Chemical Genomics Center (NCGC;<ext-link ext-link-type="uri" xlink:href="https://pubchem.ncbi.nlm.nih.gov/bioassay/624414#section=Top">https://pubchem.ncbi.nlm.nih.gov/bioassay/624414#section=Top</ext-link>). ML-SI compounds are available upon request.</p></sec><sec id="s4-11"><title>Data analysis</title><p>Data are presented as mean ± SEM. All statistical analyses were conducted using GraphPad Prism. Paired t-tests were used to compare the average of three or more experiments between treated and untreated conditions. A value of p&lt;0.05 was considered statistically significant. In the cases only individual traces were shown, the traces are representative from at least 30–40 cells, or from at least independent repeats.</p></sec></sec></body><back><ack id="ack"><title>Acknowledgement</title><p>We thank Dr. Darren Boehning for DT40-WT and IP3R-TKO cells, and Thomas Balla for the IP3R-LBD-ER construct. We also thank Richard Hume and Edward Stuenkel for comments on the manuscript, and appreciate the encouragement and helpful comments of other lab members in the Xu lab.</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>AGG, Conception and design, Acquisition of data, Analysis and interpretation of data, Drafting or revising the article, Contributed unpublished essential data or reagents</p></fn><fn fn-type="con" id="con2"><p>WW, Conception and design, Acquisition of data, Analysis and interpretation of data, Drafting or revising the article, Contributed unpublished essential data or reagents</p></fn><fn fn-type="con" id="con3"><p>CMDC, Acquisition of data, Analysis and interpretation of data, Contributed unpublished essential data or reagents</p></fn><fn fn-type="con" id="con4"><p>SAL, Acquisition of data, Analysis and interpretation of data, Contributed unpublished essential data or reagents</p></fn><fn fn-type="con" id="con5"><p>QG, Acquisition of data, Analysis and interpretation of data, Contributed unpublished essential data or reagents</p></fn><fn fn-type="con" id="con6"><p>HX, Conception and design, Analysis and interpretation of data, Drafting or revising the article, Contributed unpublished essential data or reagents</p></fn></fn-group></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alpy</surname><given-names>F</given-names></name><name><surname>Rousseau</surname><given-names>A</given-names></name><name><surname>Schwab</surname><given-names>Y</given-names></name><name><surname>Legueux</surname><given-names>F</given-names></name><name><surname>Stoll</surname><given-names>I</given-names></name><name><surname>Wendling</surname><given-names>C</given-names></name><name><surname>Spiegelhalter</surname><given-names>C</given-names></name><name><surname>Kessler</surname><given-names>P</given-names></name><name><surname>Mathelin</surname><given-names>C</given-names></name><name><surname>Rio</surname><given-names>MC</given-names></name><name><surname>Levine</surname><given-names>TP</given-names></name><name><surname>Tomasetto</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>STARD3 or STARD3NL and VAP form a novel molecular tether between late endosomes and the ER</article-title><source>Journal of Cell Science</source><volume>126</volume><fpage>5500</fpage><lpage>5512</lpage><pub-id pub-id-type="doi">10.1242/jcs.139295</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Appelqvist</surname><given-names>H</given-names></name><name><surname>Johansson</surname><given-names>AC</given-names></name><name><surname>Linderoth</surname><given-names>E</given-names></name><name><surname>Johansson</surname><given-names>U</given-names></name><name><surname>Antonsson</surname><given-names>B</given-names></name><name><surname>Steinfeld</surname><given-names>R</given-names></name><name><surname>Kågedal</surname><given-names>K</given-names></name><name><surname>Ollinger</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Lysosome-mediated apoptosis is associated with cathepsin D-specific processing of bid at Phe24, Trp48, and Phe183</article-title><source>Annals of Clinical and Laboratory Science</source><volume>42</volume><fpage>231</fpage><lpage>242</lpage></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berg</surname><given-names>TO</given-names></name><name><surname>Strømhaug</surname><given-names>E</given-names></name><name><surname>Løvdal</surname><given-names>T</given-names></name><name><surname>Seglen</surname><given-names>O</given-names></name><name><surname>Berg</surname><given-names>T</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>Use of glycyl-L-phenylalanine 2-naphthylamide, a lysosome-disrupting cathepsin C substrate, to distinguish between lysosomes and prelysosomal endocytic vacuoles</article-title><source>The Biochemical Journal</source><volume>300</volume><issue>Pt 1</issue><fpage>229</fpage><lpage>236</lpage><pub-id pub-id-type="doi">10.1042/bj3000229</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berridge</surname><given-names>MJ</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Calcium signalling remodelling and disease</article-title><source>Biochemical Society Transactions</source><volume>40</volume><fpage>297</fpage><lpage>309</lpage><pub-id pub-id-type="doi">10.1042/BST20110766</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cai</surname><given-names>X</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Cheung</surname><given-names>AK</given-names></name><name><surname>Tomlinson</surname><given-names>RC</given-names></name><name><surname>Alcázar-Román</surname><given-names>A</given-names></name><name><surname>Murphy</surname><given-names>L</given-names></name><name><surname>Billich</surname><given-names>A</given-names></name><name><surname>Zhang</surname><given-names>B</given-names></name><name><surname>Feng</surname><given-names>Y</given-names></name><name><surname>Klumpp</surname><given-names>M</given-names></name><name><surname>Rondeau</surname><given-names>JM</given-names></name><name><surname>Fazal</surname><given-names>AN</given-names></name><name><surname>Wilson</surname><given-names>CJ</given-names></name><name><surname>Myer</surname><given-names>V</given-names></name><name><surname>Joberty</surname><given-names>G</given-names></name><name><surname>Bouwmeester</surname><given-names>T</given-names></name><name><surname>Labow</surname><given-names>MA</given-names></name><name><surname>Finan</surname><given-names>PM</given-names></name><name><surname>Porter</surname><given-names>JA</given-names></name><name><surname>Ploegh</surname><given-names>HL</given-names></name><name><surname>Baird</surname><given-names>D</given-names></name><name><surname>De Camilli</surname><given-names>P</given-names></name><name><surname>Tallarico</surname><given-names>JA</given-names></name><name><surname>Huang</surname><given-names>Q</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>PIKfyve, a class III PI kinase, is the target of the small molecular IL-12/IL-23 inhibitor apilimod and a player in Toll-like receptor signaling</article-title><source>Chemistry &amp; Biology</source><volume>20</volume><fpage>912</fpage><lpage>921</lpage><pub-id pub-id-type="doi">10.1016/j.chembiol.2013.05.010</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calcraft</surname><given-names>PJ</given-names></name><name><surname>Ruas</surname><given-names>M</given-names></name><name><surname>Pan</surname><given-names>Z</given-names></name><name><surname>Cheng</surname><given-names>X</given-names></name><name><surname>Arredouani</surname><given-names>A</given-names></name><name><surname>Hao</surname><given-names>X</given-names></name><name><surname>Tang</surname><given-names>J</given-names></name><name><surname>Rietdorf</surname><given-names>K</given-names></name><name><surname>Teboul</surname><given-names>L</given-names></name><name><surname>Chuang</surname><given-names>KT</given-names></name><name><surname>Lin</surname><given-names>P</given-names></name><name><surname>Xiao</surname><given-names>R</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Lin</surname><given-names>Y</given-names></name><name><surname>Wyatt</surname><given-names>CN</given-names></name><name><surname>Parrington</surname><given-names>J</given-names></name><name><surname>Ma</surname><given-names>J</given-names></name><name><surname>Evans</surname><given-names>AM</given-names></name><name><surname>Galione</surname><given-names>A</given-names></name><name><surname>Zhu</surname><given-names>MX</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Naadp mobilizes calcium from acidic organelles through two-pore channels</article-title><source>Nature</source><volume>459</volume><fpage>596</fpage><lpage>600</lpage><pub-id pub-id-type="doi">10.1038/nature08030</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cerny</surname><given-names>J</given-names></name><name><surname>Feng</surname><given-names>Y</given-names></name><name><surname>Yu</surname><given-names>A</given-names></name><name><surname>Miyake</surname><given-names>K</given-names></name><name><surname>Borgonovo</surname><given-names>B</given-names></name><name><surname>Klumperman</surname><given-names>J</given-names></name><name><surname>Meldolesi</surname><given-names>J</given-names></name><name><surname>McNeil</surname><given-names>PL</given-names></name><name><surname>Kirchhausen</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>The small chemical vacuolin-1 inhibits Ca(2+)-dependent lysosomal exocytosis but not cell resealing</article-title><source>EMBO Reports</source><volume>5</volume><fpage>883</fpage><lpage>888</lpage><pub-id pub-id-type="doi">10.1038/sj.embor.7400243</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Christensen</surname><given-names>KA</given-names></name><name><surname>Myers</surname><given-names>JT</given-names></name><name><surname>Swanson</surname><given-names>JA</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>pH-dependent regulation of lysosomal calcium in macrophages</article-title><source>Journal of Cell Science</source><volume>115</volume><fpage>599</fpage><lpage>607</lpage></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clapham</surname><given-names>DE</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Calcium signaling</article-title><source>Cell</source><volume>131</volume><fpage>1047</fpage><lpage>1058</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2007.11.028</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coen</surname><given-names>K</given-names></name><name><surname>Flannagan</surname><given-names>RS</given-names></name><name><surname>Baron</surname><given-names>S</given-names></name><name><surname>Carraro-Lacroix</surname><given-names>LR</given-names></name><name><surname>Wang</surname><given-names>D</given-names></name><name><surname>Vermeire</surname><given-names>W</given-names></name><name><surname>Michiels</surname><given-names>C</given-names></name><name><surname>Munck</surname><given-names>S</given-names></name><name><surname>Baert</surname><given-names>V</given-names></name><name><surname>Sugita</surname><given-names>S</given-names></name><name><surname>Wuytack</surname><given-names>F</given-names></name><name><surname>Hiesinger</surname><given-names>PR</given-names></name><name><surname>Grinstein</surname><given-names>S</given-names></name><name><surname>Annaert</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Lysosomal calcium homeostasis defects, not proton pump defects, cause endo-lysosomal dysfunction in PSEN-deficient cells</article-title><source>The Journal of Cell Biology</source><volume>198</volume><fpage>23</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1083/jcb.201201076</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cárdenas</surname><given-names>C</given-names></name><name><surname>Miller</surname><given-names>RA</given-names></name><name><surname>Smith</surname><given-names>I</given-names></name><name><surname>Bui</surname><given-names>T</given-names></name><name><surname>Molgó</surname><given-names>J</given-names></name><name><surname>Müller</surname><given-names>M</given-names></name><name><surname>Vais</surname><given-names>H</given-names></name><name><surname>Cheung</surname><given-names>KH</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Parker</surname><given-names>I</given-names></name><name><surname>Thompson</surname><given-names>CB</given-names></name><name><surname>Birnbaum</surname><given-names>MJ</given-names></name><name><surname>Hallows</surname><given-names>KR</given-names></name><name><surname>Foskett</surname><given-names>JK</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Essential regulation of cell bioenergetics by constitutive InsP3 receptor Ca2+ transfer to mitochondria</article-title><source>Cell</source><volume>142</volume><fpage>270</fpage><lpage>283</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2010.06.007</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dickson</surname><given-names>EJ</given-names></name><name><surname>Duman</surname><given-names>JG</given-names></name><name><surname>Moody</surname><given-names>MW</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Hille</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Orai-STIM-mediated Ca2+ release from secretory granules revealed by a targeted Ca2+ and pH probe</article-title><source>Proceedings of the National Academy of Sciences of the United States of America</source><volume>109</volume><fpage>E3539</fpage><lpage>E3548</lpage><pub-id pub-id-type="doi">10.1073/pnas.1218247109</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dong</surname><given-names>XP</given-names></name><name><surname>Cheng</surname><given-names>X</given-names></name><name><surname>Mills</surname><given-names>E</given-names></name><name><surname>Delling</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>F</given-names></name><name><surname>Kurz</surname><given-names>T</given-names></name><name><surname>Xu</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>The type IV mucolipidosis-associated protein TRPML1 is an endolysosomal iron release channel</article-title><source>Nature</source><volume>455</volume><fpage>992</fpage><lpage>996</lpage><pub-id pub-id-type="doi">10.1038/nature07311</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drin</surname><given-names>G</given-names></name><name><surname>von Filseck</surname><given-names>JM</given-names></name><name><surname>Čopič</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>New molecular mechanisms of inter-organelle lipid transport</article-title><source>Biochemical Society Transactions</source><volume>44</volume><fpage>486</fpage><lpage>578</lpage><pub-id pub-id-type="doi">10.1042/BST20150265</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eden</surname><given-names>ER</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The formation and function of ER-endosome membrane contact sites</article-title><source>Biochimica Et Biophysica Acta</source><pub-id pub-id-type="doi">10.1016/j.bbalip.2016.01.020</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Friedman</surname><given-names>JR</given-names></name><name><surname>Dibenedetto</surname><given-names>JR</given-names></name><name><surname>West</surname><given-names>M</given-names></name><name><surname>Rowland</surname><given-names>AA</given-names></name><name><surname>Voeltz</surname><given-names>GK</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Endoplasmic reticulum-endosome contact increases as endosomes traffic and mature</article-title><source>Molecular Biology of the Cell</source><volume>24</volume><pub-id pub-id-type="doi">10.1091/mbc.E12-10-0733</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gerasimenko</surname><given-names>JV</given-names></name><name><surname>Tepikin</surname><given-names>AV</given-names></name><name><surname>Petersen</surname><given-names>OH</given-names></name><name><surname>Gerasimenko</surname><given-names>OV</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Calcium uptake via endocytosis with rapid release from acidifying endosomes</article-title><source>Current Biology</source><volume>8</volume><fpage>1335</fpage><lpage>1338</lpage><pub-id pub-id-type="doi">10.1016/S0960-9822(07)00565-9</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haller</surname><given-names>T</given-names></name><name><surname>Dietl</surname><given-names>P</given-names></name><name><surname>Deetjen</surname><given-names>P</given-names></name><name><surname>Völkl</surname><given-names>H</given-names></name></person-group><year iso-8601-date="1996">1996a</year><article-title>The lysosomal compartment as intracellular calcium store in MDCK cells: a possible involvement in InsP3-mediated Ca2+ release</article-title><source>Cell Calcium</source><volume>19</volume><fpage>157</fpage><lpage>165</lpage><pub-id pub-id-type="doi">10.1016/S0143-4160(96)90084-6</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haller</surname><given-names>T</given-names></name><name><surname>Völkl</surname><given-names>H</given-names></name><name><surname>Deetjen</surname><given-names>P</given-names></name><name><surname>Dietl</surname><given-names>P</given-names></name></person-group><year iso-8601-date="1996">1996b</year><article-title>The lysosomal Ca2+ pool in MDCK cells can be released by ins(1,4,5)P3-dependent hormones or thapsigargin but does not activate store-operated Ca2+ entry</article-title><source>The Biochemical Journal</source><volume>319</volume><fpage>909</fpage><lpage>912</lpage><pub-id pub-id-type="doi">10.1042/bj3190909</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hayashi</surname><given-names>T</given-names></name><name><surname>Rizzuto</surname><given-names>R</given-names></name><name><surname>Hajnoczky</surname><given-names>G</given-names></name><name><surname>Su</surname><given-names>TP</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>MAM: more than just a housekeeper</article-title><source>Trends in Cell Biology</source><volume>19</volume><fpage>81</fpage><lpage>88</lpage><pub-id pub-id-type="doi">10.1016/j.tcb.2008.12.002</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hofer</surname><given-names>AM</given-names></name><name><surname>Fasolato</surname><given-names>C</given-names></name><name><surname>Pozzan</surname><given-names>T</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Capacitative Ca2+ entry is closely linked to the filling state of internal Ca2+ stores: a study using simultaneous measurements of ICRAC and intraluminal [Ca2+]</article-title><source>The Journal of Cell Biology</source><volume>140</volume><fpage>325</fpage><lpage>334</lpage><pub-id pub-id-type="doi">10.1083/jcb.140.2.325</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jadot</surname><given-names>M</given-names></name><name><surname>Colmant</surname><given-names>C</given-names></name><name><surname>Wattiaux-De Coninck</surname><given-names>S</given-names></name><name><surname>Wattiaux</surname><given-names>R</given-names></name></person-group><year iso-8601-date="1984">1984</year><article-title>Intralysosomal hydrolysis of glycyl-L-phenylalanine 2-naphthylamide</article-title><source>The Biochemical Journal</source><volume>219</volume><fpage>965</fpage><lpage>970</lpage><pub-id pub-id-type="doi">10.1042/bj2190965</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jefferies</surname><given-names>HB</given-names></name><name><surname>Cooke</surname><given-names>FT</given-names></name><name><surname>Jat</surname><given-names>P</given-names></name><name><surname>Boucheron</surname><given-names>C</given-names></name><name><surname>Koizumi</surname><given-names>T</given-names></name><name><surname>Hayakawa</surname><given-names>M</given-names></name><name><surname>Kaizawa</surname><given-names>H</given-names></name><name><surname>Ohishi</surname><given-names>T</given-names></name><name><surname>Workman</surname><given-names>P</given-names></name><name><surname>Waterfield</surname><given-names>MD</given-names></name><name><surname>Parker</surname><given-names>PJ</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>A selective PIKfyve inhibitor blocks PtdIns(3,5)P(2) production and disrupts endomembrane transport and retroviral budding</article-title><source>EMBO Reports</source><volume>9</volume><fpage>164</fpage><lpage>170</lpage><pub-id pub-id-type="doi">10.1038/sj.embor.7401155</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>DE</given-names></name><name><surname>Ostrowski</surname><given-names>P</given-names></name><name><surname>Jaumouillé</surname><given-names>V</given-names></name><name><surname>Grinstein</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The position of lysosomes within the cell determines their luminal pH</article-title><source>The Journal of Cell Biology</source><volume>212</volume><fpage>677</fpage><lpage>692</lpage><pub-id pub-id-type="doi">10.1083/jcb.201507112</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jurkovicova</surname><given-names>D</given-names></name><name><surname>Sedlakova</surname><given-names>B</given-names></name><name><surname>Lacinova</surname><given-names>L</given-names></name><name><surname>Kopacek</surname><given-names>J</given-names></name><name><surname>Sulova</surname><given-names>Z</given-names></name><name><surname>Sedlak</surname><given-names>J</given-names></name><name><surname>Krizanova</surname><given-names>O</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Hypoxia differently modulates gene expression of inositol 1,4,5-trisphosphate receptors in mouse kidney and HEK 293 cell line</article-title><source>Annals of the New York Academy of Sciences</source><volume>1148</volume><fpage>421</fpage><lpage>427</lpage><pub-id pub-id-type="doi">10.1196/annals.1410.034</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kilpatrick</surname><given-names>BS</given-names></name><name><surname>Eden</surname><given-names>ER</given-names></name><name><surname>Schapira</surname><given-names>AH</given-names></name><name><surname>Futter</surname><given-names>CE</given-names></name><name><surname>Patel</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Direct mobilisation of lysosomal Ca2+ triggers complex Ca2+ signals</article-title><source>Journal of Cell Science</source><volume>126</volume><fpage>60</fpage><lpage>66</lpage><pub-id pub-id-type="doi">10.1242/jcs.118836</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kinnear</surname><given-names>NP</given-names></name><name><surname>Boittin</surname><given-names>FX</given-names></name><name><surname>Thomas</surname><given-names>JM</given-names></name><name><surname>Galione</surname><given-names>A</given-names></name><name><surname>Evans</surname><given-names>AM</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Lysosome-sarcoplasmic reticulum junctions. A trigger zone for calcium signaling by nicotinic acid adenine dinucleotide phosphate and endothelin-1</article-title><source>The Journal of Biological Chemistry</source><volume>279</volume><fpage>54319</fpage><lpage>54326</lpage><pub-id pub-id-type="doi">10.1074/jbc.M406132200</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kiselyov</surname><given-names>K</given-names></name><name><surname>Yamaguchi</surname><given-names>S</given-names></name><name><surname>Lyons</surname><given-names>CW</given-names></name><name><surname>Muallem</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Aberrant Ca2+ handling in lysosomal storage disorders</article-title><source>Cell Calcium</source><volume>47</volume><fpage>103</fpage><lpage>114</lpage><pub-id pub-id-type="doi">10.1016/j.ceca.2009.12.007</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lemons</surname><given-names>RM</given-names></name><name><surname>Thoene</surname><given-names>JG</given-names></name></person-group><year iso-8601-date="1991">1991</year><article-title>Mediated calcium transport by isolated human fibroblast lysosomes</article-title><source>The Journal of Biological Chemistry</source><volume>266</volume><fpage>14378</fpage><lpage>14382</lpage></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lewis</surname><given-names>RS</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>The molecular choreography of a store-operated calcium channel</article-title><source>Nature</source><volume>446</volume><fpage>284</fpage><lpage>287</lpage><pub-id pub-id-type="doi">10.1038/nature05637</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lloyd-Evans</surname><given-names>E</given-names></name><name><surname>Morgan</surname><given-names>AJ</given-names></name><name><surname>He</surname><given-names>X</given-names></name><name><surname>Smith</surname><given-names>DA</given-names></name><name><surname>Elliot-Smith</surname><given-names>E</given-names></name><name><surname>Sillence</surname><given-names>DJ</given-names></name><name><surname>Churchill</surname><given-names>GC</given-names></name><name><surname>Schuchman</surname><given-names>EH</given-names></name><name><surname>Galione</surname><given-names>A</given-names></name><name><surname>Platt</surname><given-names>FM</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Niemann-Pick disease type C1 is a sphingosine storage disease that causes deregulation of lysosomal calcium</article-title><source>Nature Medicine</source><volume>14</volume><fpage>1247</fpage><lpage>1255</lpage><pub-id pub-id-type="doi">10.1038/nm.1876</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>López-Sanjurjo</surname><given-names>CI</given-names></name><name><surname>Tovey</surname><given-names>SC</given-names></name><name><surname>Prole</surname><given-names>DL</given-names></name><name><surname>Taylor</surname><given-names>CW</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Lysosomes shape Ins(1,4,5)P3-evoked Ca2+ signals by selectively sequestering Ca2+ released from the endoplasmic reticulum</article-title><source>Journal of Cell Science</source><volume>126</volume><fpage>289</fpage><lpage>300</lpage><pub-id pub-id-type="doi">10.1242/jcs.116103</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsumoto</surname><given-names>H</given-names></name><name><surname>Miyazaki</surname><given-names>S</given-names></name><name><surname>Matsuyama</surname><given-names>S</given-names></name><name><surname>Takeda</surname><given-names>M</given-names></name><name><surname>Kawano</surname><given-names>M</given-names></name><name><surname>Nakagawa</surname><given-names>H</given-names></name><name><surname>Nishimura</surname><given-names>K</given-names></name><name><surname>Matsuo</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Selection of autophagy or apoptosis in cells exposed to ER-stress depends on ATF4 expression pattern with or without CHOP expression</article-title><source>Biology Open</source><volume>2</volume><fpage>1084</fpage><lpage>1090</lpage><pub-id pub-id-type="doi">10.1242/bio.20135033</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCue</surname><given-names>HV</given-names></name><name><surname>Wardyn</surname><given-names>JD</given-names></name><name><surname>Burgoyne</surname><given-names>RD</given-names></name><name><surname>Haynes</surname><given-names>LP</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Generation and characterization of a lysosomally targeted, genetically encoded Ca(2+)-sensor</article-title><source>The Biochemical Journal</source><volume>449</volume><fpage>449</fpage><lpage>457</lpage><pub-id pub-id-type="doi">10.1042/BJ20120898</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Medina</surname><given-names>DL</given-names></name><name><surname>Di Paola</surname><given-names>S</given-names></name><name><surname>Peluso</surname><given-names>I</given-names></name><name><surname>Armani</surname><given-names>A</given-names></name><name><surname>De Stefani</surname><given-names>D</given-names></name><name><surname>Venditti</surname><given-names>R</given-names></name><name><surname>Montefusco</surname><given-names>S</given-names></name><name><surname>Scotto-Rosato</surname><given-names>A</given-names></name><name><surname>Prezioso</surname><given-names>C</given-names></name><name><surname>Forrester</surname><given-names>A</given-names></name><name><surname>Settembre</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Gao</surname><given-names>Q</given-names></name><name><surname>Xu</surname><given-names>H</given-names></name><name><surname>Sandri</surname><given-names>M</given-names></name><name><surname>Rizzuto</surname><given-names>R</given-names></name><name><surname>De Matteis</surname><given-names>MA</given-names></name><name><surname>Ballabio</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Lysosomal calcium signalling regulates autophagy through calcineurin and TFEB</article-title><source>Nature Cell Biology</source><volume>17</volume><fpage>288</fpage><lpage>299</lpage><pub-id pub-id-type="doi">10.1038/ncb3114</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meikle</surname><given-names>PJ</given-names></name><name><surname>Brooks</surname><given-names>DA</given-names></name><name><surname>Ravenscroft</surname><given-names>EM</given-names></name><name><surname>Yan</surname><given-names>M</given-names></name><name><surname>Williams</surname><given-names>RE</given-names></name><name><surname>Jaunzems</surname><given-names>AE</given-names></name><name><surname>Chataway</surname><given-names>TK</given-names></name><name><surname>Karageorgos</surname><given-names>LE</given-names></name><name><surname>Davey</surname><given-names>RC</given-names></name><name><surname>Boulter</surname><given-names>CD</given-names></name><name><surname>Carlsson</surname><given-names>SR</given-names></name><name><surname>Hopwood</surname><given-names>JJ</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Diagnosis of lysosomal storage disorders: evaluation of lysosome-associated membrane protein LAMP-1 as a diagnostic marker</article-title><source>Clinical Chemistry</source><volume>43</volume><fpage>1325</fpage><lpage>1335</lpage></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Menteyne</surname><given-names>A</given-names></name><name><surname>Burdakov</surname><given-names>A</given-names></name><name><surname>Charpentier</surname><given-names>G</given-names></name><name><surname>Petersen</surname><given-names>OH</given-names></name><name><surname>Cancela</surname><given-names>JM</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Generation of specific Ca(2+) signals from Ca(2+) stores and endocytosis by differential coupling to messengers</article-title><source>Current Biology</source><volume>16</volume><fpage>1931</fpage><lpage>1937</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2006.07.070</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mindell</surname><given-names>JA</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Lysosomal acidification mechanisms</article-title><source>Annual Review of Physiology</source><volume>74</volume><fpage>69</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.1146/annurev-physiol-012110-142317</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morgan</surname><given-names>AJ</given-names></name><name><surname>Davis</surname><given-names>LC</given-names></name><name><surname>Galione</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Imaging approaches to measuring lysosomal calcium</article-title><source>Methods in Cell Biology</source><volume>126</volume><fpage>159</fpage><lpage>195</lpage><pub-id pub-id-type="doi">10.1016/bs.mcb.2014.10.031</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morgan</surname><given-names>AJ</given-names></name><name><surname>Galione</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>NAADP induces pH changes in the lumen of acidic Ca2+ stores</article-title><source>The Biochemical Journal</source><volume>402</volume><fpage>301</fpage><lpage>310</lpage><pub-id pub-id-type="doi">10.1042/BJ20060759</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morgan</surname><given-names>AJ</given-names></name><name><surname>Platt</surname><given-names>FM</given-names></name><name><surname>Lloyd-Evans</surname><given-names>E</given-names></name><name><surname>Galione</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Molecular mechanisms of endolysosomal Ca2+ signalling in health and disease</article-title><source>The Biochemical Journal</source><volume>439</volume><fpage>349</fpage><lpage>374</lpage><pub-id pub-id-type="doi">10.1042/BJ20110949</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mu</surname><given-names>TW</given-names></name><name><surname>Fowler</surname><given-names>DM</given-names></name><name><surname>Kelly</surname><given-names>JW</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Partial restoration of mutant enzyme homeostasis in three distinct lysosomal storage disease cell lines by altering calcium homeostasis</article-title><source>PLoS Biology</source><volume>6</volume><fpage>e26</fpage><pub-id pub-id-type="doi">10.1371/journal.pbio.0060026</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oslowski</surname><given-names>CM</given-names></name><name><surname>Urano</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Measuring ER stress and the unfolded protein response using mammalian tissue culture system</article-title><source>Methods in Enzymology</source><volume>490</volume><fpage>71</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.1016/B978-0-12-385114-7.00004-0</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peppiatt</surname><given-names>CM</given-names></name><name><surname>Collins</surname><given-names>TJ</given-names></name><name><surname>Mackenzie</surname><given-names>L</given-names></name><name><surname>Conway</surname><given-names>SJ</given-names></name><name><surname>Holmes</surname><given-names>AB</given-names></name><name><surname>Bootman</surname><given-names>MD</given-names></name><name><surname>Berridge</surname><given-names>MJ</given-names></name><name><surname>Seo</surname><given-names>JT</given-names></name><name><surname>Roderick</surname><given-names>HL</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>2-Aminoethoxydiphenyl borate (2-APB) antagonises inositol 1,4,5-trisphosphate-induced calcium release, inhibits calcium pumps and has a use-dependent and slowly reversible action on store-operated calcium entry channels</article-title><source>Cell Calcium</source><volume>34</volume><fpage>97</fpage><lpage>108</lpage><pub-id pub-id-type="doi">10.1016/S0143-4160(03)00026-5</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Phillips</surname><given-names>MJ</given-names></name><name><surname>Voeltz</surname><given-names>GK</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Structure and function of ER membrane contact sites with other organelles</article-title><source>Nature Reviews. Molecular Cell Biology</source><volume>17</volume><fpage>69</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.1038/nrm.2015.8</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pryor</surname><given-names>PR</given-names></name><name><surname>Mullock</surname><given-names>BM</given-names></name><name><surname>Bright</surname><given-names>NA</given-names></name><name><surname>Gray</surname><given-names>SR</given-names></name><name><surname>Luzio</surname><given-names>JP</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>The role of intraorganellar Ca(2+) in late endosome-lysosome heterotypic fusion and in the reformation of lysosomes from hybrid organelles</article-title><source>The Journal of Cell Biology</source><volume>149</volume><fpage>1053</fpage><lpage>1062</lpage><pub-id pub-id-type="doi">10.1083/jcb.149.5.1053</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Querfurth</surname><given-names>HW</given-names></name><name><surname>Haughey</surname><given-names>NJ</given-names></name><name><surname>Greenway</surname><given-names>SC</given-names></name><name><surname>Yacono</surname><given-names>PW</given-names></name><name><surname>Golan</surname><given-names>DE</given-names></name><name><surname>Geiger</surname><given-names>JD</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Expression of ryanodine receptors in human embryonic kidney (HEK293) cells</article-title><source>The Biochemical Journal</source><volume>334</volume><fpage>79</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.1042/bj3340079</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reddy</surname><given-names>A</given-names></name><name><surname>Caler</surname><given-names>EV</given-names></name><name><surname>Andrews</surname><given-names>NW</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Plasma membrane repair is mediated by Ca(2+)-regulated exocytosis of lysosomes</article-title><source>Cell</source><volume>106</volume><fpage>157</fpage><lpage>169</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(01)00421-4</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rocha</surname><given-names>N</given-names></name><name><surname>Kuijl</surname><given-names>C</given-names></name><name><surname>van der Kant</surname><given-names>R</given-names></name><name><surname>Janssen</surname><given-names>L</given-names></name><name><surname>Houben</surname><given-names>D</given-names></name><name><surname>Janssen</surname><given-names>H</given-names></name><name><surname>Zwart</surname><given-names>W</given-names></name><name><surname>Neefjes</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Cholesterol sensor ORP1L contacts the ER protein VAP to control Rab7-RILP-p150 Glued and late endosome positioning</article-title><source>The Journal of Cell Biology</source><volume>185</volume><fpage>1209</fpage><lpage>1225</lpage><pub-id pub-id-type="doi">10.1083/jcb.200811005</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rudolf</surname><given-names>R</given-names></name><name><surname>Mongillo</surname><given-names>M</given-names></name><name><surname>Rizzuto</surname><given-names>R</given-names></name><name><surname>Pozzan</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Looking forward to seeing calcium</article-title><source>Nature Reviews. Molecular Cell Biology</source><volume>4</volume><fpage>579</fpage><lpage>586</lpage><pub-id pub-id-type="doi">10.1038/nrm1153</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scott</surname><given-names>CC</given-names></name><name><surname>Gruenberg</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Ion flux and the function of endosomes and lysosomes: pH is just the start: the flux of ions across endosomal membranes influences endosome function not only through regulation of the luminal pH</article-title><source>BioEssays</source><volume>33</volume><fpage>103</fpage><lpage>110</lpage><pub-id pub-id-type="doi">10.1002/bies.201000108</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Settembre</surname><given-names>C</given-names></name><name><surname>Fraldi</surname><given-names>A</given-names></name><name><surname>Medina</surname><given-names>DL</given-names></name><name><surname>Ballabio</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Signals from the lysosome: a control centre for cellular clearance and energy metabolism</article-title><source>Nature Reviews. Molecular Cell Biology</source><volume>14</volume><fpage>283</fpage><lpage>296</lpage><pub-id pub-id-type="doi">10.1038/nrm3565</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>D</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Yao</surname><given-names>Z</given-names></name><name><surname>Dibble</surname><given-names>S</given-names></name><name><surname>Dong</surname><given-names>XP</given-names></name><name><surname>Yu</surname><given-names>T</given-names></name><name><surname>Lieberman</surname><given-names>AP</given-names></name><name><surname>Showalter</surname><given-names>HD</given-names></name><name><surname>Xu</surname><given-names>H</given-names></name><name><surname>Dong</surname><given-names>Xian-ping</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Lipid storage disorders block lysosomal trafficking by inhibiting a TRP channel and lysosomal calcium release</article-title><source>Nature Communications</source><volume>3</volume><fpage>731</fpage><pub-id pub-id-type="doi">10.1038/ncomms1735</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steen</surname><given-names>M</given-names></name><name><surname>Kirchberger</surname><given-names>T</given-names></name><name><surname>Guse</surname><given-names>AH</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>NAADP mobilizes calcium from the endoplasmic reticular Ca(2+) store in T-lymphocytes</article-title><source>The Journal of Biological Chemistry</source><volume>282</volume><fpage>18864</fpage><lpage>18871</lpage><pub-id pub-id-type="doi">10.1074/jbc.M610925200</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thastrup</surname><given-names>O</given-names></name><name><surname>Cullen</surname><given-names>PJ</given-names></name><name><surname>Drøbak</surname><given-names>BK</given-names></name><name><surname>Hanley</surname><given-names>MR</given-names></name><name><surname>Dawson</surname><given-names>AP</given-names></name></person-group><year iso-8601-date="1990">1990</year><article-title>Thapsigargin, a tumor promoter, discharges intracellular Ca2+ stores by specific inhibition of the endoplasmic reticulum Ca2(+)-ATPase</article-title><source>Proceedings of the National Academy of Sciences of the United States of America</source><volume>87</volume><fpage>2466</fpage><lpage>2470</lpage><pub-id pub-id-type="doi">10.1073/pnas.87.7.2466</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van der Kant</surname><given-names>R</given-names></name><name><surname>Neefjes</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Small regulators, major consequences - Ca²⁺ and cholesterol at the endosome-ER interface</article-title><source>Journal of Cell Science</source><volume>127</volume><fpage>929</fpage><lpage>938</lpage><pub-id pub-id-type="doi">10.1242/jcs.137539</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Várnai</surname><given-names>P</given-names></name><name><surname>Balla</surname><given-names>A</given-names></name><name><surname>Hunyady</surname><given-names>L</given-names></name><name><surname>Balla</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Targeted expression of the inositol 1,4,5-triphosphate receptor (IP3R) ligand-binding domain releases Ca2+ via endogenous IP3R channels</article-title><source>Proceedings of the National Academy of Sciences of the United States of America</source><volume>102</volume><fpage>7859</fpage><lpage>7864</lpage><pub-id pub-id-type="doi">10.1073/pnas.0407535102</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Dong</surname><given-names>XP</given-names></name><name><surname>Samie</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Cheng</surname><given-names>X</given-names></name><name><surname>Goschka</surname><given-names>A</given-names></name><name><surname>Shen</surname><given-names>D</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Harlow</surname><given-names>J</given-names></name><name><surname>Zhu</surname><given-names>MX</given-names></name><name><surname>Clapham</surname><given-names>DE</given-names></name><name><surname>Ren</surname><given-names>D</given-names></name><name><surname>Xu</surname><given-names>H</given-names></name><name><surname>Dong</surname><given-names>Xian-ping</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>TPC proteins are phosphoinositide- activated sodium-selective ion channels in endosomes and lysosomes</article-title><source>Cell</source><volume>151</volume><fpage>372</fpage><lpage>383</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2012.08.036</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>MM</given-names></name><name><surname>Buchanan</surname><given-names>J</given-names></name><name><surname>Luik</surname><given-names>RM</given-names></name><name><surname>Lewis</surname><given-names>RS</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Ca2+ store depletion causes STIM1 to accumulate in ER regions closely associated with the plasma membrane</article-title><source>The Journal of Cell Biology</source><volume>174</volume><fpage>803</fpage><lpage>813</lpage><pub-id pub-id-type="doi">10.1083/jcb.200604014</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>H</given-names></name><name><surname>Ren</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Lysosomal physiology</article-title><source>Annual Review of Physiology</source><volume>77</volume><fpage>57</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1146/annurev-physiol-021014-071649</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoshimori</surname><given-names>T</given-names></name><name><surname>Yamamoto</surname><given-names>A</given-names></name><name><surname>Moriyama</surname><given-names>Y</given-names></name><name><surname>Futai</surname><given-names>M</given-names></name><name><surname>Tashiro</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="1991">1991</year><article-title>Bafilomycin A1, a specific inhibitor of vacuolar-type H(+)-ATPase, inhibits acidification and protein degradation in lysosomes of cultured cells</article-title><source>The Journal of Biological Chemistry</source><volume>266</volume><fpage>17707</fpage><lpage>17712</lpage></element-citation></ref></ref-list></back><sub-article article-type="article-commentary" id="SA1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.15887.020</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Clapham</surname><given-names>David E</given-names></name><role>Reviewing editor</role><aff id="aff4"><institution>Howard Hughes Medical Institute, Boston Children's Hospital</institution>, <country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.</p></boxed-text><p>Thank you for submitting your article &quot;The Endoplasmic Reticulum, Not the pH Gradient in the Lysosome, Are the Source of Calcium to Lysosomes&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by David Clapham as the Reviewing Editor and Eve Marder as the Senior Editor. One of the three reviewers, Murali Prakriya, has agreed to share his identity.</p><p>The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.</p><p>Summary:</p><p>Garrity et al. challenge the previously held view that lysosomal V-ATPase driven-acidification provides the driving force for lysosomal Ca<sup>2+</sup> refilling. Using various manipulations designed to inhibit the proton pump (Baf-A or Con-A) and several Ca<sup>2+</sup> imaging tools that directly and indirectly monitor lysosomal Ca<sup>2+</sup>, the authors show that the proton pump by is likely not responsible for refilling of the lysosomal Ca<sup>2+</sup> store. Rather the authors report that manipulations that deplete ER Ca<sup>2+</sup> stores also affect refilling of the lysosomal compartment, suggesting a functional and possibly physical coupling of the ER and lysosomal Ca<sup>2+</sup> stores. The authors include new results using OG-BAPTA-dextran showing that depletion of ER Ca<sup>2+</sup> stores by thapsigargin, or inhibition of IP3Rs by the membrane permeable Xestospongin inhibited the lysosomal Ca<sup>2+</sup> content. An interesting point is that the previously postulated H<sup>+</sup>-dependent Ca<sup>2+</sup> transporter must operate with cytosolic free Ca<sup>2+</sup> level of 100 nM and therefore be extremely high affinity. The present mechanism, although not identified, would be a low affinity uptake mechanism.</p><p>Overall the data represent quite a challenging and intriguing new concept. Although most of the data appear convincing, some major open questions remain to be addressed. We feel these can be remedied within a month by additional experiments.</p><p>Essential revisions:</p><p>1) You need at least one convincing experiment showing that inhibiting the V-ATPase increases pH (needs to be measured) but doesn't affect store [Ca<sup>2+</sup>]. In the Christensen studies, inhibiting V-ATPase with Baf (similar to the treatment used in this paper) increased luminal pH to ~ 7.0 (where the Ca<sup>2+</sup> imaging dye should work well) and drastically decreased [Ca<sup>2+</sup>]lys from ~ mM to μM. Although you added new OG-BAPTA imaging, it needs calibration. You should show the data measuring the pH and [Ca<sup>2+</sup>]. The bar graphs (<xref ref-type="fig" rid="fig3">Figure 3H</xref> and <xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3F</xref>) do not provide information about the kinetics of the Ca<sup>2+</sup> change and how they may (or may not) correlate with the Ca<sup>2+</sup> changes reported by the GCaMP ML1 indicator shown in the majority of the data. Example traces of the lysosomal Ca<sup>2+</sup> indicator in response to lysosomal and ER Ca<sup>2+</sup> store depletion should be shown.</p><p>2) The authors contend that previous [Ca<sup>2+</sup>]lumen measurements were unreliable because of the pH-sensitivity of the dyes. In the Christensen et al. studies, however, the pH of each lysosome was monitored and used to calibrate the <italic>K</italic><sub>d</sub> of the dye. The Christensen studies (using lysosomes that do not overexpress any Ca-releasing channel) suggest that [Ca<sup>2+</sup>]lumen faithfully follows [pH]lumen. Other studies using 45Ca uptake measurement also support the importance of pH gradient (e.g. Lemons &amp; Thoene 1991, JBC 266: 14378). However, the pH sensitivity of the indicators used in the present paper were not tested in situ. We suggest you test the pH sensitivity of your Ca<sup>2+</sup> indicator in situ by placing a small mouth pipette electrode containing low pH solution+ x [Ca<sup>2+</sup>] next to tagged channel indicator and measure its sensitivity to Ca<sup>2+</sup> changes. Please provide more detail in the Discussion why you think the previously published measurements were erroneous.</p><p>3) A triple IP3R knockout cell line was used to assess the proposed role of IP3Rs in refilling the lysosomal store. However, in contrast to the authors' theory, this does not have a lysosomal Ca<sup>2+</sup> defect. The authors attribute this to an unknown compensatory mechanism. Please examine whether the Xestospongin abolishes ML1-SA1 responses in the triple IP3R KO cells and show the kinetics of the response. If the responses in the IP3R KO are not affected, and the kinetics now differ, the results would provide an additional layer of confidence for the proposed role of IP3Rs in lysosomal refilling.</p></body></sub-article><sub-article article-type="reply" id="SA2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.15887.021</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><p><italic>1) You need at least one convincing experiment showing that inhibiting the V-ATPase increases pH (needs to be measured) but doesn't affect store [Ca<sup>2+</sup>]. In the Christensen studies, inhibiting V-ATPase with Baf (similar to the treatment used in this paper) increased luminal pH to ~ 7.0 (where the Ca<sup>2+</sup> imaging dye should work well) and drastically decreased [Ca<sup>2+</sup>]lys from ~ mM to μM. Although you added new OG-BAPTA imaging, it needs calibration. You should show the data measuring the pH and [Ca<sup>2+</sup>].</italic></p><p>We performed the experiments as suggested by the reviewers. First, we monitored lysosomal pH under different conditions using Oregon green 488-dextran, a commonly- used luminal pH indicator [1, 2] (see Methods and new <xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3I</xref>). Using the calibration that we made for OG-488-dextran (see <xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3I</xref>), we showed that lysosomal pH (pH<sub>L</sub>), which is ~4.8 under the resting condition, increased dramatically within minutes to ~ pH 7.0 upon treatment of Baf-A1 (5 μM) or NH4Cl (10 mM) in HEK293 cells stably expressing ML1 (see <xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3J, K</xref>). Second, based on the calibration for the luminal Ca<sup>2+</sup> dye OG-BAPTA-dextran (see <xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3C</xref>), we found that the intra-lysosomal [Ca<sup>2+</sup>] ([Ca<sup>2+</sup>]Ly), which was ~ 360 μM under the resting condition, dropped quickly to ~ 100 μM upon ML-SA1 application (see <xref ref-type="fig" rid="fig3">Figure 3H, I</xref>). Note that at pH 4.5, OG-BAPTA- dextran’s <italic>K</italic>d is ~300 μM (<xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3C</xref>), allowing measurement of Ca<sup>2+</sup> ranging from 30 (0.1 <italic>K</italic>d) to 3,000 (10 <italic>K</italic>d) μM [3]. At the resting pH<sub>L</sub> of 4.8 in the HEK cells, OG-BAPTA- dextran’s working range is 130-1,300 μM (<italic>K</italic>d ~ 130 μM). Overall, all these values are in rough agreement with previous measurements [1, 3, 4].</p><p>Upon Baf-A1 and NH4Cl treatment to increase lysosomal pH, the fluorescence intensity of OG-BAPTA-dextran increased mildly, following the pH<sub>L</sub> changes (<xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3J, K</xref>). If the effect of lysosomal pH is exclusively on the <italic>K</italic>d of OG-BAPTA-dextran, these results would suggest that [Ca<sup>2+</sup>]Ly dropped significantly, as concluded by Christensen et al. [5]. However, in addition to triggering lysosomal Ca<sup>2+</sup> release, as proposed by Christensen et al. [5], lysosomal pH elevation is known to affect [Ca<sup>2+</sup>]Ly or its measurement via several additional mechanisms. Therefore, the interpretation offered by Christensen et al. might be too simplistic.</p><p>First, a change in lysosomal pH may cause a significant change in luminal Ca<sup>2+</sup> buffering. In most studies dealing with cytosolic Ca<sup>2+</sup>, the total versus free [Ca<sup>2+</sup>] in the intracellular organelles (stores) are often not separately-considered since these two parameters are interrelated. Whereas the total [Ca<sup>2+</sup>]Ly is reported to be in the low mM range (5-10 mM), free [Ca<sup>2+</sup>]Ly is generally agreed to be in the high μM range (100-500 μM; 360 μM in the current study) [3]. Therefore, the lysosome lumen must contain a substantial amount of Ca<sup>2+</sup> buffers [3]. Ca<sup>2+</sup> buffers in the acidic compartments and ER are known to bind Ca<sup>2+</sup> much better at neutral pH (H<sup>+</sup> and Ca<sup>2+</sup> compete with each other for Ca<sup>2+</sup> buffers) [4]. Hence increasing pH<sub>L</sub> from 4.8 to 7.0 may effectively reduce free [Ca<sup>2+</sup>]Ly without necessarily triggering lysosomal Ca<sup>2+</sup> release and affecting total [Ca<sup>2+</sup>]Ly.</p><p>Second, lysosomal pH may act on luminal Ca<sup>2+</sup> dyes by affecting their chromophore fluorescence and Ca<sup>2+</sup>-binding affinity (<italic>K</italic>d) [3]. Because <italic>K</italic>d is dropped more than 1,000 times when pH<sub>L</sub> is increased from 4.8 to 7.0 (<xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3C</xref>), perfect calibration is currently impossible. Note that in the Christensen studies, which were conducted in the activated macrophages, the basal pH<sub>L</sub>is ~ pH 3.8 [5]. When pH<sub>L</sub>was increased from 3.8 to 5.0, the free [Ca<sup>2+</sup>]Ly was already dropped to ~ 10 μM (see <xref ref-type="fig" rid="fig3">Figure 3</xref> of ref. [5]). However, in most studies including the current study, lysosomal pH is between 4.5 to 5.0 [1]. Hence, the mechanism proposed by Christensen et al., might not apply to most cell types whose basal pH<sub>L</sub>is close to pH 5.0. In addition, because of high levels of luminal Ca<sup>2+</sup> buffers, the amount of releasable Ca<sup>2+</sup> is high. Hence, a depletion of free [Ca<sup>2+</sup>]Ly to low μM is expected to produce a large cytosolic Ca<sup>2+</sup> increase, which did not occur (see below). In the current study, upon ML-SA1 application to deplete the stores, free [Ca<sup>2+</sup>]Ly dropped from 360 to 100 μM (<xref ref-type="fig" rid="fig3">Figure 3I</xref>). Hence, within physiological ranges of lysosomal pH (4.8 -7.0) and Ca<sup>2+</sup>, the fluorescence signals of OG-BAPTA- dextran dyes might be nearly saturated, and this would prevent accurate determinations of [Ca<sup>2+</sup>]Ly changes when pH<sub>L</sub>is increased from 4.8 to 7.0 upon Baf-A1 or NH4Cl application. Note that at pH 7.0, OG-BAPTA-dextran’s <italic>K</italic>d is ~0.1 μM (Figure—figure supplement 3C), which is not suitable for measuring Ca<sup>2+</sup> over 10 μM.</p><p>Third, prolonged lysosomal pH manipulations may also indirectly affect lysosomal Ca<sup>2+</sup> homeostasis, for instance, via membrane fusion and fission between compartments containing different amounts of Ca<sup>2+</sup>, H<sup>+</sup>, and their buffers.</p><p>Fourth,although elevating lysosomal pH might trigger lysosomal Ca<sup>2+</sup> release, the accompanied increase in cytoplasmic Ca<sup>2+</sup> was rather small (20-40 nM) (see refs. [4, 5]). This minor increase is more consistent with the interpretation that other pH-dependent processes contribute to the changes of OG-BAPTA fluorescence upon Baf-A1 and NH4Cl application. In addition, the instantaneous changes (following pH increase and decrease) of Ca<sup>2+</sup> probe fluorescence (see Figure 5 in ref. [5] and <xref ref-type="fig" rid="fig3">Figure 3</xref> in ref. [4]) are inconsistent with the slow rates of Ca<sup>2+</sup> leak (τ = 6 min; see <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1E</xref>) and re-uptake (τ = 2 min; see <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2F</xref> &amp; <xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2C</xref>). Furthermore, given the pH-sensitivity of the Fura-2 dyes, even the observed minor increase (20-40 nM) in cytosolic Ca<sup>2+</sup>, based on instantaneous increases of Fura-2 ratios, could be mostly due to the effects of lysosomal proton release on the Fura-2 dyes (see <xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3</xref>).</p><p>Because of the reasons listed above, in the current study, we used the luminal Ca<sup>2+</sup> dyes for free [Ca<sup>2+</sup>]Ly measurement only in the experiments during which the pH remains unchanged.</p><p><italic>The bar graphs (<xref ref-type="fig" rid="fig3">Figure 3H</xref> and <xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3F</xref>) do not provide information about the kinetics of the Ca2+ change and how they may (or may not) correlate with the Ca2+ changes reported by the GCamP ML1 indicator shown in the majority of the data. Example traces of the lysosomal Ca2+ indicator in response to lysosomal and ER Ca2+ store depletion should be shown.</italic></p><p>The example traces were now added into new <xref ref-type="fig" rid="fig3">Figure 3I</xref> and <xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3H</xref>. Note that due to the photo-bleaching and small signal, we had to minimize the problem by reducing data acquisition. With the calibration curve, we measured lysosomal Ca<sup>2+</sup> changes under different experimental manipulations. Whereas ML-SA1 application significantly depleted lysosomal Ca<sup>2+</sup> contents (see new <xref ref-type="fig" rid="fig3">Figure 3I</xref>), TG treatment only slightly reduced lysosomal Ca<sup>2+</sup> after 5- 10 min (<xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3H</xref>). Although a quick drop in [Ca<sup>2+</sup>]Ly may cause a transient increase in cytosolic [Ca<sup>2+</sup>], it may also liberate certain amount of Ca<sup>2+</sup> from the Ca<sup>2+</sup>-bound buffers, resulting in a delayed reduction in free [Ca<sup>2+</sup>]Ly. Therefore, as suspected by the reviewer, the kinetics of the GCaMP3-ML1 and OG-BAPTA-dextran were not perfectly correlated.</p><p>This is an excellent suggestion – thank you! See response #1 regarding [Ca<sup>2+</sup>]Ly measurement.</p><p>In GCaMP3-ML1-positive vacuoles that were isolated from HEK-GCaMP3-ML1 cells and released into the dish, we moved patch pipettes containing either a “high Ca<sup>2+</sup>” (10 mM) internal solution or a “low pH” solution (140 mM KCl, 1 mM EGTA, 20 mM MES, 10 mM Glucose, pH adjusted to pH 2.0) close to the vacuoles to produce a “puffing” effect. We showed that GCaMP3- ML1 responded to both Ca<sup>2+</sup> and pH (see <xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3E</xref>), but not to the “puffing” of the standard internal solution. These data suggest that our GCaMP3-ML1 probe, in addition to being a good indicator for measuring Ca<sup>2+</sup> released from lysosomes, may also respond to lysosomal proton release, for instance, upon GPN and Baf-A1 application. Our results suggest that caution is necessary in designing the experiments to study the interaction between lysosomal Ca<sup>2+</sup> and lysosomal pH. We propose that BAPTA-AM control experiments should be routinely performed in any lysosomal Ca<sup>2+</sup> studies.</p><p><italic>Please provide more detail in the Discussion why you think the previously published measurements were erroneous.</italic></p><p>We added a new paragraph in the Discussion (second paragraph), and included a discussion in the Results.</p><p>Results: “In contrast, treatment of cells with Baf-A1 or NH<sub>4</sub>Cl markedly increased lysosomal pH from 4.8 to 7.0 (<xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3J, K</xref>). Such large pH elevations may cause dramatic changes in both <italic>K</italic><sub>d</sub> of OG-BAPTA-dextran (see <xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3C</xref>) and luminal Ca<sup>2+</sup> buffering capability (Dickson et al., 2012; Morgan et al., 2015), preventing accurate determinations of [Ca<sup>2+]</sup>LY under these pH manipulations”.</p><p>Discussion:“Lysosomal pH gradient is thought to be essential for the maintenance of high free [Ca<sup>2+</sup>]Ly (Calcraft et al., 2009; Christensen et al., 2002; Dickson et al., 2012; Lloyd-Evans et al., 2008; Shen et al., 2012). However, in addition to triggering lysosomal Ca<sup>2+</sup> release, as proposed by Christensen et al. (Christensen et al., 2002), lysosomal pH elevation is also known to affect [Ca<sup>2+</sup>]Ly or its measurement via several other mechanisms. Whereas the total [Ca<sup>2+</sup>]Ly is reported to be in the low mM range (5-10 mM), free [Ca<sup>2+</sup>]Ly is generally agreed to be in the high μM range (100-500 μM) (Morgan et al., 2015). Therefore, lysosome lumen must contain substantial amount of Ca<sup>2+</sup> buffers (Morgan et al., 2015). Ca<sup>2+</sup> buffers in the acidic compartments and ER are known to bind Ca<sup>2+</sup> much better at neutral pH (Dickson et al., 2012). Hence increasing pH<sub>L</sub>from 4.8 to 7.0 may effectively reduce free [Ca<sup>2+</sup>]Ly without necessarily triggering lysosomal Ca<sup>2+</sup> release and affecting total [Ca<sup>2+</sup>]Ly. Consistent with such interpretation, a compelling study recently demonstrated that in secretory granules and the ER, increasing luminal pH changed the Ca<sup>2+</sup> buffering capacity of both Ca<sup>2+</sup> containing compartments intraluminally to reduce free [Ca<sup>2+</sup>], while causing a minimal (20 nM) increase in cytosolic Ca<sup>2+</sup> (Dickson et al., 2012). Additionally, lysosomal pH may act on luminal Ca<sup>2+</sup> dyes by affecting their chromophore fluorescence and Ca<sup>2+</sup>-binding affinity (<italic>K</italic>d) (Morgan et al., 2015). Because <italic>K</italic>d is dropped more than 1,000 times when pH<sub>L</sub>is increased from 4.8 to 7.0, perfect calibration is near impossible. Furthermore, prolonged lysosomal pH manipulations may also indirectly affect lysosomal Ca<sup>2+</sup> homeostasis, for instance, via membrane fusion and fission between compartments containing different amounts of Ca<sup>2+</sup>, H<sup>+</sup>, and their buffers. Finally, although elevating lysosomal pH may trigger lysosomal Ca<sup>2+</sup> release, the accompanied increase in cytoplasmic Ca<sup>2+</sup> was rather small (20- 40 nM) (Christensen et al., 2002; Dickson et al., 2012). Moreover, the instantaneous changes (following pH increase and decrease) of Ca<sup>2+</sup> probe fluorescence (Christensen et al., 2002; Dickson et al., 2012) are inconsistent with the slow rates of Ca<sup>2+</sup> leak and re-uptake demonstrated in the current study”.</p><p><italic>3) A triple IP3R knockout cell line was used to assess the proposed role of IP3Rs in refilling the lysosomal store. However, in contrast to the authors' theory, this does not have a lysosomal Ca2+ defect. The authors attribute this to an unknown compensatory mechanism. Please examine whether the Xestospongin abolishes ML1-SA1 responses in the triple IP3R KO cells and show the kinetics of the response. If the responses in the IP3R KO are not affected, and the kinetics now differ, the results would provide an additional layer of confidence for the proposed role of IP3Rs in lysosomal refilling.</italic></p><p>This is another excellent suggestion. We performed these experiments as suggested, and showed that although lysosomal Ca<sup>2+</sup> refilling still occurred in IP3R TKO cells, the refilling kinetics were much slower than WT cells (see <xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2C</xref>), and more importantly, refilling were completely insensitive to IP3R inhibitions (see <xref ref-type="fig" rid="fig3">Figure 3D-F</xref>).</p><p>References:</p><p>1) Johnson, D.E., et al., The position of lysosomes within the cell determines their luminal pH. J Cell Biol, 2016. 212(6): p. 677-92.</p><p>2) DiCiccio, J.E. and B.E. Steinberg, Lysosomal pH and analysis of the counter ion pathways that support acidification. J Gen Physiol, 2011. 137(4): p. 385-90.</p><p>3) Morgan, A.J., L.C. Davis, and A. Galione, Imaging approaches to measuring lysosomal calcium. Methods Cell Biol, 2015. 126: p. 159-95.</p><p>4) Dickson, E.J., et al., Orai-STIM-mediated Ca2+ release from secretory granules revealed by a targeted Ca2+ and pH probe. Proceedings of the National Academy of Sciences of the United States of America, 2012. 109(51): p. E3539-48.</p><p>5) Christensen, K.A., J.T. Myers, and J.A. Swanson, pH-dependent regulation of lysosomal calcium in macrophages. Journal of cell science, 2002. 115(Pt 3): p. 599-607.</p></body></sub-article></article>